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Abstract 
Evaluation of oral implants involves at least three major components: statistical methods, 
study design and success criteria. 
 
The aims of the current thesis were to investigate how different statistical methods affect the 
outcome of oral implant treatment and to statistically determine if any dependence among 
implants placed in the same jaw exists. If so - how would that affect the outcome and the type 
and amount of missing data (withdrawn patients)? Furthermore, the aims were to evaluate 
patient, implant and treatment characteristics to find possible prognostic factors for implant 
failure and to study the impact of variances with or without handling dependence using the 
Jackknife technique. 
 
Four prospective multi-centre studies, involving 487 patients and 1738 implants, were pooled 
to create a database for these elaborations. The database was divided into subgroups based on 
significant different outcomes regarding implant failures. Four jaw-bone combinations 
(Combination I-IV) were established, and in study IV - Combinations I-III were pooled and 
compared with Combination IV. Statistical methods used were: life table analyses, confidence 
intervals, chi2 tests, step by step multivariate analyses, post hoc analyses, log rank tests and 
the Jackknife technique. 
 
The result of the current statistical investigations demonstrated that dependence among 
implants placed in the same jaw existed. The impact of missing data was shown to depend on, 
if the patients were selectively or randomly withdrawn. A random selection could reach at the 
most 50% without affecting the CSR. However, if the selection was based on e.g. treated jaw, 
the outcomes were significantly different. Patient characteristics such as jaw, jaw-bone 
quality, jaw-shape and combination of these factors, and also on implant length and treatment 
protocol, showed significant differences. Patients with jaw shape D or E and bone-quality 4 
were e.g. identified with a significantly higher risk for implant failure than all of the other 
combinations. Both life table analyses, using CI and log rank tests, demonstrated after the 
variances were calculated via the Jackknife technique significantly lower success rates for 
Combination IV. The p-values were “inadequately” stronger, however, when using a log rank 
test and ignoring the established dependence. 
 
Based on these results it was stated that, following established dependence among implants 
within the same jaw, this should never be ignored when evaluating oral implant outcomes. 
Two methods were found possible to use to handle this dependence, the “one implant per 
patient” or the Jackknife technique if variances are part of the evaluation. Missing data is 
inevitable and will affect the outcome, and therefore a description of the characteristics of 
withdrawn patients should be presented. Jaw-combination IV showed the lowest success rate 
and would therefore be the most appropriate population to use, when evaluating new 
improved oral implant systems in order to prove significantly different follow-up outcome. 
 
Keywords: Statistical methods, oral implants dependence, prognostic risk factors, 
multivariate analysis, bone-combination, Jackknife, log rank test, variance. 
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Introduction  
 
The use of oral implants 
The modern era of oral implants started more than 40 years ago, when Professor 
Per-Ingvar Brånemark almost accidentally discovered that titanium components 
could integrate into living bone (Brånemark, 1969), a condition he referred to as 
osseointegration. Subsequently, this finding was developed into a clinical 
procedure, internationally presented in Toronto in 1982 (Zarb, 1983); the 
consensus of that meeting has with time become a milestone for many of the 
oral implant treatments used today. 
   
The osseointegration procedure  
The original clinical procedure ad modum Brånemark consists of two surgical 
steps followed by the prosthetic rehabilitation (Brånemark et al., 1969, 1977; 
Figure 1).  
 
Figure 1 
Treatment steps from implant  
placement to prosthetic restoration. 
 
During stage one surgery, a full-
thickness muco-periostal flap is 
elevated under strict sterile 
conditions. The implant sites are 
then prepared by successive drills of 
gradually increasing diameter 
(Figure 2). The individual sites are 
subsequently countersunk and 
generally threaded before the 
titanium implants are placed into the 
bone-sites, using a non-traumatic 
surgical technique 
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Figure 2 
Preparation of implant sites by 
successive incremented drill diameters. 
 
 
All drilling is performed under 
extensive cooling with saline to  
avoid overheating the bone (Adell et 
al., 1985; Sutter et al., 1992; Brägger 
et al., 1995). Following implant 
placement, the muco-periostal flap is 
re-adapted over the implant sites. 
Second stage surgery - abutment 
connection - takes place after 
undisturbed healing of the implants 
(three months for lower and six 
months for upper jaws). During this 
procedure, the mucosa perforating 
extensions are attached to the 
implants.  
 
Finally, the prosthetic treatment is completed when the full bridge construction 
is fabricated and attached to the abutments without imposing any static forces on 
the anchoring units (Rangert B et al., 1989; Alkan et al., 2004; Natali et al., 
2006). A well-balanced occlusion of the construction is ensured and maintained 
against the dentition of the opposing jaw (Figure 3). 
 
Figure 3 
Lower full arch bridge and radio- 
graphs of corresponding implant. 
 
Since the technique was 
internationally introduced in 1982, it 
has been extensively used all over 
the world, and the outcome has been 
profoundly evaluated, using strict 
follow-up protocols (Albrektsson & 
Lekholm, 1989; Henry, 1999; Naert 
et al., 2001; Esposito et al., 2001:a, 
2005; Gapski et al., 2003).  
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Consequently, treatment ad modum Brånemark has become a “gold standard” 
for oral implant treatment protocols used today (Millennium research group, 
2005). 
 
Possible prognostic factors 
The outcome of oral implant treatment may depend on several technique related 
factors (Brånemark et al., 1977); such as patient characteristics and selection, 
implant components and skill of the performing clinicians. Six considerations 
have been identified by Albrektsson et al. (1981) as important for the 
establishment of implant integration in bone. The influence of these factors on 
treatment outcome has subsequently been confirmed by others (e.g. Friberg et 
al., 1991; Wennerberg et al., 1996; Ivanoff et al., 2001; Gapski et al., 2003).  
 
Patient characteristics 
As always, patient selection and examination are important for the outcome of 
the treatment (Adell et al., 1986; Lekholm, 1998; Andersson et al., 1995; van 
Steenberghe et al., 2002; Sugermann & Barber, 2002). The patient related 
characteristic specifically highlighted by Albrektsson et al. (1981) is the status 
of the bone of the implant site. This was later developed into an index ( Lekholm 
& Zarb, 1985), related to bone quality (cortical versus marrow bone) and jaw-
shape (degree of resorption). 
 
 Figure 4
 Lekholm & Zarb index related to 
jaw shape and bone quality. 
 
Lekholm & Zarb 1985                                                             
This Lekholm & Zarb index (Figure 
4) has frequently been applied, due 
to its ease of use and strong 
predictive value for implant failures 
(Friberg et al., 1991; Truhlar et al., 
1994; Sennerby & Roos, 1998; 
Hutton et al., 1995). Smoking is 
another patient related factor 
strongly correlated with implant 
failures (Bain & Moy, 1993; 
DeBruyn & Collaert, 1994), due to 
the influence of nicotine on the bone 
vascularisation. 
 
Technique related factors  
Two factors related to the clinical performance have been specifically pointed 
out by Albrektsson et al. (1981) as important for enabling a good treatment 
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outcome. The first is the use of a non-traumatic surgical technique to minimize 
tissue violence (Eriksson & Albrektsson, 1984; Eriksson et al., 1984). This has 
been confirmed in several other reports as one of the most important factors in 
decreasing the frequency of early implant failures (Cordioli et al., 1997; Ercoli et 
al., 2004). The second technique related factor put forward by Albrektsson et al. 
(1981) is implant loading conditions, i.e. the need for an undisturbed healing 
period of 3 months for lower and 6 months for upper jaws. Today, the actual 
healing times have been somewhat reduced for routine cases (Schnitman et al., 
1997; Ericsson et al., 2000; Roccuzzo & Wilson, 2002; Cochran et al., 2002; 
Bischof et al., 2004). However, even micro movements during the primary 
healing period of the implants are still not accepted (Gapski et al., 2003; 
Cochran et al., 2004). 
 
Implant characteristics 
With regard to implant characteristics, three aspects were identified by 
Albrektsson et al. (1981), starting with (1) the implant material - where the 
authors recommended the use of pure non-alloyed titanium, followed by (2) the 
implant design – for which they suggested use of threaded implants to minimize 
implant movements and to enhance the implant surface area. The third implant 
related variable mentioned was (3) the implant finish, where a turned surface 
was recommended in order to improve cellular contacts with the implant. The 
ideal surface was, therefore, identified as - neither polished nor too rough.  
 
Skill of the clinicians   
Of course, all the technique and patient-selection related aspects may be 
associated with the experience and skill of the treating doctor, and reports 
indicate that a learning curve exists as doctors start to use oral implant treatment 
protocols (Lambert et al., 1997; Albrektsson, 2001).   
 
Consequently, the bone status of the implant sites, the skill of the clinicians and 
the biocompatibility of the components used are all factors that may influence 
the treatment result and may thus also be possible prognostic risk factors for the 
clinical outcome. Therefore, these factors, one by one or together, ought to be 
assessed when performing result evaluations. However, most authors routinely 
assess only the implant related factors when performing studies on oral implant 
systems – i.e. - (1) the implant material - (2) the macro design of the implant 
and - (3) the finish or micro design of the implant surface (Piattelli et al., 2002; 
Bolind et al., 2005; Rasmusson et al., 2005; Shalabi, 2006).   
 
Introduction of concurrent oral implant systems 
At about the same time as the Brånemark procedure became public, researchers 
in Germany and Switzerland also presented concurrent implant innovations 
(Albrektsson and Wennerberg, 2005). The development of the Frialit technique, 
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a German implant system (Tubingen, Heidelberg, Germany), was begun in 1974 
by Professor Schulte (Schulte, 1981). This system has become known for its root 
shaped implants with step wise increasing diameters, from the beginning 
produced in a ceramic material (Al2O3) (Schulte & Heimke, 1980). The system 
has been further developed for more than two decades since its introduction. 
Today Dentsply International Inc. (Pennsylvania, US), the current owner of the 
Frialit implant system, markets three different implant lines in titanium 
(Ankylos, Frialit, Xive), of which two are derived from the original Frialit 
implant. The Ankylos implant system has a progressive thread-design, while 
Frialit and Xive still have the root-analogue form combined with an internal 
abutment locking connection (Dentsply home page, 2007-01-31).  
 
In 1980, an implant system introduced by the Institute Straumann AG (Basel, 
Switzerland) became publicly available (Schroeder et al., 1976). The system was 
developed and introduced by Professor Schroeder in collaboration with the ITI 
research institute in Bern. The Straumann oral implant system was introduced as 
the first one-stage implant system, eliminating the second surgical phase. The 
implants have a 2-3 mm band of smooth surface intended to be placed just 
caudal to the soft tissue margin (Straumann home page, 2007-01-31). The 
implants initially had a TPS-surface, which was later replaced by a SLA-surface, 
both of which have been extensively documented (Eckert et al., 2005). 
However, a new surface texture called SLA-active is currently used for three ITI 
implant-design options (Standard, Standard Plus and Tapered) (Straumann home 
page, 2007-01-31). The Institute Straumann and Nobel Biocare are presently the 
leading implant manufacturers on the market (Millenium report, 2005).  
 
Nobel Biocare AB (currently Nobel Biocare Holding AG, Zurich, Switzerland), 
the manufacturer of the original Brånemark implant and previously known for 
its conservative approach and extensive clinical documentation, has recently 
developed a wide range of new implant lines. The classical two-stage threaded 
design with an external hexagonal connection has partly been replaced by new 
designs like Nobel Direct; a one-piece implant sculptured directly in the patients 
mouth and loaded immediately (Nobel Biocare home page, 2007-01-31).Via 
purchase in the mid-nineties Nobel Biocare also introduced a completely new 
implant line called Nobel Replace (Sullivan, 2001). This system has an internal 
hexed-abutment connection and is also available in a range of designs such as 
tapered, straight or with the marginal part sculptured (Emms, 2007). Regarding 
surface texture, Nobel Biocare has moved from their original turned-surface, 
pure titanium grade 1 (ad modum Brånemark) to a current rougher one called 
TiUnite, titanium grade 4 (Rocci et al., 2003; Friberg et al., 2005). 
  
During the eighties several more implant brands were introduced, not all of 
which became successful and lasting and some even had to be removed from the 
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market, such as the IMZ (Fredensfeld, Germany) and Core-Vent (California, 
USA) (Esposito et al., 1997). These two implant systems had a hollow basket 
form instead of the full threaded design, and the IMZ implant was HA coated 
(Esposito et al., 1997). Unfortunately, this surface treatment did not withstand 
the demands of long-term bonding of the implant to the surrounding bone. 
Instead, the surface material frequently fractured and subsequently caused 
infections in the surrounding tissues and resorption of the bone (Esposito et al., 
1997). The Core-Vent design also induced similar bone reactions and with time 
these implants often tended to fail (Malmqvist & Sennerby, 1990).  
 
Astra Tech AB (Mölndal, Sweden) started a clinical research program in the 
mid-eighties to document their implant system, known for its internal conical 
connection between implant and abutment, which is called the conical seal 
design (Astra Tech home page, 2007-01-31).  The system has a roughened 
implant surface called TiOblast, with over 10-years of clinical follow-up 
experience (Rasmusson et al., 2005). However, the Astra Tech company has 
also introduced new features in their components; such as micro threads and a 
connective contour design, which are aimed to enhance the marginal bone 
profile (Astra Tech home page, 2007-01-31; Rasmusson et al., 2001). The new 
implant surface texture OsseoSpeed, a fluoride-modified surface, is gradually 
replacing the TiOblast-surface. Furthermore, Astra tech has recently redesigned 
the implant-abutment connection and the company is therefore in a transitional 
phase regarding compatibility between older and new components (Astra Tech 
home page, 2007-01-31). 
 
The basic principles of the Brånemark system have been adopted by many other 
implant systems (Misch & Misch, 1992; Lazzarra et al., 1996; U. S. Food and 
Drug Administration, 2007). For instance, 3i (Implant Innovation inc., Florida, 
USA) and Lifecore Dental (Lifecore Biomedical inc., Minnesota, USA), both 
companies on the top ten list by market share (Annual industry report, 2005), 
introduced generic products. They are designed to mimic the original Brånemark 
implant system, referring to the long-term clinical documentation available for 
turned and threaded implants (Adell et al., 1981; Ekelund et al., 2003; Lekholm 
et al., 2006). However, both companies now also have their own development of 
new oral implant systems with company specific macro and micro designs 
(surface technique; Lifecore Biomedicals home page 2007-01-31; Implant 
innovations home page, 2007-01-31).  
 
Consequently, there is currently a broad variety of manufactures and implant 
systems on the market.  Many of these are, however, plain copycats referring to 
old documentation of generic techniques. Other systems are constantly 
introducing components with new features and thus miss the link to long-term 
clinical documentation of previous implant lines. The need for sound evaluation 
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of new components and systems is of course obvious and has to be performed in 
a structured and scientific way, including a correct statistical handling of the 
long-term follow-up data.  
 
Application possibilities 
From the beginning (1965-1980), oral implants were mainly used to treat totally 
edentulous patients to give them better chewing and speech function and 
improve their social lives (Brånemark et al., 1977; Albrektsson et al., 1987). The 
most common condition to be treated with rigid fixed bridgework was in 
mandibles (Lindquist & Carlsson, 1985). Maxillae were of course also treated 
with the same type of prosthetic rehabilitation (Taylor, 1991; Desjardins, 1992). 
In some cases, the rigid full fixed bridges were replaced by a more cost effective 
overdenture treatment protocol, often requiring only 2 implants (Zitzmann et al., 
2006). In the Netherlands, overdentures even became the only implant treatment 
procedure supported by their national dental health insurance system (Cune et 
al., 1997). However, when overdentures were used in upper jaws, typically 
presenting poor bone qualities and small jawbone volumes, the success rates 
were often less favourable (Jemt el al., 1992; Hutton et al., 1995; Jemt et al., 
1996). Still, the successful treatment outcome of totally edentulous and orally 
handicapped patients in time further opened up the treatment panorama.  
 
Therefore, dentists around the world started to use osseointegrated implants to 
treat all types of edentulism, i.e. from single to multiple tooth loss (Lorenzoni et 
al., 2003; Levin, 2006; Palmer, 2000; Lekholm et al., 2006). In single tooth 
replacement, the patients are often young and their treatment result must have a 
lifetime perspective. When using single implants in the incisor region the 
aesthetic is of course also very demanding (Kourtis, 2007). In partially 
edentulous jaws, where more than one tooth has to be replaced, the implants are 
generally connected by a fixed framework. Such constructions can be either 
screw retained or cemented (Keith et al., 1999; Uludag & Celic, 2006). A 
method by which partial fixed bridges could be supported by connection to 
natural teeth has also been described; however variable outcomes for both the 
teeth involved and the implant bridges have been reported (Åstrand et al., 1991; 
Schlumberger, 1998).  
 
In cases with insufficient jawbone volume for implant placement, additional 
advanced surgery may be required using various grafting protocols prior to 
implant placement (Adell et al., 1990:a; Köndell et al., 1996; Kahnberg et al., 
1989, 1999). The grafting can be performed as a one- or two-stage procedure, 
depending on the severity of the bone resorption and the health of the patient 
(Lundgren et al., 1997; Nyström et al., 2002).  Recently, a method has become 
available as a complement to bone grafting, using oversized implants 
(Zygomaticus implant, developed by Nobel Biocare AB, Göteborg, Sweden) 
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placed in the zygomatic bone, a few conventionally sized implants placed within 
the alveolar bone, and a fixed construction (Higuchi, 2000; Brånemark et al., 
2004; Malevez et al., 2004).   
 
Finally, implants can be used in orthodontic treatment, where secure fixation is 
required in order to move misaligned teeth without displacing those already 
correctly aligned (Oncag, 2007). The “Onplant” implant system, developed and 
introduced by Nobel Biocare AB (Göteborg, Sweden), was designed for such 
treatment purposes (Ödman et al., 1988).  
 
Consequently, oral implants are today used over a broad range of applications 
which must be individually and scientifically assessed before the outcomes can 
be claimed to be safe and predictable.   
 
Follow up aspects 
Guidelines for the performance and evaluation of clinical trials have been 
available and used for decades (Pocock, 1983) for introducing pharmaceutical 
products. However, the evaluation procedure, used for pharmaceutical products, 
is not suitable for oral implants; one of many products within the family of 
medical devices. Instead detailed evaluation protocols are needed in these cases 
to give researchers and authorities useful comparable data. The first attempt to 
introduce such a protocol was at a Harvard consensus meeting in 1978 
(Schnitman & Schulman, 1980).  
 
Basically, study design and statistical evaluations are considered of utmost 
importance in all clinical research, whether for pharmaceutical or biomedical 
products. The “gold rule” demands a clinical trial to be: controlled, double-
blinded, randomised and prospective (Pocock et al., 1983; Herrmann, 2003). 
However, when evaluating medical devices such as oral implants, the clinical 
testing was not very demanding until the Medical Device Directive of 1993 
(Liedström, 1995); the Food and Drug Administration’s (FDA:s) stricter policy 
of registration applications (510(k) or PMA) was also introduced in the 90’s (U. 
S. Food and Drug Administration home page 2007-02-02). The authorities are 
still quite liberal, when it comes to clinical documentation on oral implants. A 
full quality assurance certification (Liedström, 1995) gives the manufacturers 
the right to put a device on the market without any new data, if generic design 
and treatment modality can be referred to. However, the certification is normally 
only based on the production of the devices rather than on the clinical 
performance and the outcome of the treatment. Furthermore, only when the 
manufacturer is claiming a superior design or completely new features, 
laboratory or clinical studies are required (U. S. Food and Drug Administration).  
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Consequently, the decision to document new products or changed features of 
new components today seems to be made by manufacturers and/or researchers 
mainly randomly. Unfortunately, this means that risks of severe clinical 
problems may only be exposed after the products have been introduced onto the 
market and after placed in patients, which of course is not acceptable. 
 
Study designs 
Study designs can be divided into retrospective and prospective protocols, with 
or without using a control group. Case reports, the least advanced method of 
presenting oral implant results, have been and are often still used when 
introducing new methods and components (James et al., 1974; Dilek et al., 
2007). This way of presenting outcomes can be valuable for example when 
presenting a complication or a solution to a problem (Strietzel et al., 2006). The 
Journal of oral and maxillofacial implants (JOMI) is one of the peer-reviewed 
journals that also present case reports in almost every number (Bousdras et al., 
2006). However, for presenting results of a treatment procedure per se, case 
reports are of very restricted value. 
 
Retrospective studies, based on the experience of one clinic using a new 
treatment protocol or component, were frequently published in the eighties  
(Cox et al., 1987;  Adell et al., 1981; Dalise, 1988). This type of study design is 
seldom used today because it is statistically untidy. Instead, retrospective 
multicentre-studies, where more than one clinic has been responsible for the 
treatment and evaluation of outcome, are currently being published (Ko et al., 
2006; Misch et al., 2006). The disadvantage with retrospective studies is that 
different follow up times have often been used by the different centres, as some 
patients may have been treated years ago while others have been treated just 
recently (Babbush & Shimura, 1993). Subsequently, the evaluation time may be 
long and the patient population large at the start, whereas the number of patients 
evaluated at the end of the full time period might be low. Therefore, the 
cumulative success rates for the longest follow-up periods may be based on just 
a few percent of the entire study population (Ferringo et al., 2002); which of 
course is not acceptable.  
 
Prospective multicenter-trials, in which all clinicians follow a strict study 
protocol with well-defined success criteria and the statistical evaluations decided 
from the start, became a “gold standard” for oral implants when introduced in 
the 90´s (Lekholm et al., 1994; Jemt et al., 1996; Henry et al., 1996; Friberg et 
al., 1997). Such studies can also be used to identify risk factors for variables 
tested, such as bone quality and quantity (Lekholm et al., 1994; Jemt et al., 
1996; Friberg et al., 1997). When comparing different implant systems, 
treatment modalities, or side effects such as marginal bone-loss, it has been 
recommended to use a controlled, randomised and prospective multicenter-study 
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design (Olsson et al., 1995; Örtorp & Jemt, 2006; Iacono & Cochran, 2007). 
However, to compare the success rates of two different implant systems would 
require thousands of patients, since the expected success rates may be 95-99 % 
(Pocock, 1983). For natural reasons, double-blinded studies are not an easy 
option in these situations.  
 
In order to identify success rates and to establish reasons for failures, a few 
researchers have tried to combine the outcomes from different reports using 
meta-analyses (Esposito et al., 2001a; Shalabi et al., 2006; Proskin et al., 2007). 
However, problems with these techniques do occur - when the study design, 
success criteria and statistical methods have not been the same for all the studies 
included in the evaluation.  
 
Consequently, studies on oral implants most often use a diversity of study 
designs and statistical methods (Babbush et al., 1986; Adell et al., 1990:b; 
Arvidson et al., 1992; Buchs et al., 1995; Wheeler et al., 1996; Lazzara et al., 
1996; Åstrand et al., 2002; Esposito, 2001a; Shin et al., 2006; Jemt & Hager, 
2006). The number of oral implant reports is also rapidly increasing (2838 in 
PubMed 2006-12-03), but only a few of these are based on 5 years or longer 
follow-up periods (Heydenrijk et al., 1998; Ekelund et al., 2003; Eckert et al., 
2003; Attard & Zarb, 2004; Hallman et al., 2005; Lekholm et al., 1999, 2006). 
The purpose of every study should be clearly stated in advance, and the purpose 
should subsequently influence the choice of study design and statistical 
techniques used to enable reliable and correct assessments of the data.  
 
Success criteria 
The intention when placing implants into the body is, of course, that they should 
last a lifetime. Therefore, it is obvious that before implants are placed it should 
also be known that they will function for such a long period. Consequently, 
there is a need for establishing how to measure the success of new oral implant 
systems before their introduction to the market. An early attempt to present 
some basic guidelines for success criteria for oral implant treatment was 
suggested by Schnitman & Schulman (1980). Other researchers (Smith & Zarb, 
1989; Buser et al., 1997) have subsequently presented their own criteria, of 
which those of Albrektsson et al. (1986) have become the most frequently used.  
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Lekholm et al. (1994) suggested some minor adjustments to the Albrektsson 
success criteria, in order to make them suitable for individual implant 
evaluations. Basically, the modified criteria focused on the definition of failures 
as follows: implants found to be mobile or affected by persisting and incurable 
soft tissue or mechanical problems, should be regarded  as failures. An implant 
was also considered as a failure when the marginal bone loss reached the apical 
third of the implant during the follow-up period. Other factors, such as 
interrupted marginal bone resorption, persistent pain, restorative complications 
and/or paresthesia were reported separately, but without influencing the implant 
success rate per se. 
  
A further development of the Albrektsson and associates success criteria has 
been suggested by those authors (Albrektsson, 1993). They allocated the 
outcome of the implants into four groups: success, survival, failure or 
”unaccounted for”. By doing so, all implants could be individually characterized 
and evaluated.   
 
Consequently, it is important that success criteria are defined and agreed upon 
before any follow-up study is performed, as this may facilitate the researchers to 
comply with the study protocols and may enable comparison between different 
study outcomes later on. 
   
Objectives of different statistical methods 
In order to confine the scope of this thesis, the statistical terms and analyses 
commonly used in oral implant treatment studies are reviewed.  
The Albrektsson success criteria are summarized as follows: 
- an individual, unattached implant should be immobile when tested 
clinically.  
- a radiograph should not demonstrate any evidence of peri-implant 
radiolucency, 
- the vertical bone loss should not exceed 0.2 mm annually,  
following the implant’s first year of service. 
- no signs or symptoms such as pain, infection, neuropathies, parestesia,  
or harm to the mandibular canal, should be reported.  
- an overall success rate for the system should be at least 85% after 
a 5-year observation period and 80% after 10-years. 
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Descriptive statistics 
All statistical questions have aspects to be considered before choosing the most 
appropriate evaluation model. Mean and standard deviation (spread) have often 
been referred to as sufficient and helpful statistics to describe the distribution of 
variables assessed (Altman, 1991; Gellerstedt, 2006). Defining a distribution for 
a specific variable will, however, help to choose between a parametric or non-
parametric statistical model. Parametric statistics require that the data be 
normally distributed or similar, and are generally considered to be more 
efficient; to give greater power to the analyses. Non-parametric methods are 
more robust and can, on the other hand, be used on all types of distributions; but 
are generally regarded as more complex procedures. In order to select the 
correct statistical method, it is also important to determine which type of 
measurements needs to be collected. Parametric and correlation methods are 
preferably used in analysing quantitative and numerical measurements, while 
qualitative data, i.e. nominal and ordinal measurements, demand a non-
parametric evaluation (Siegel & Castellan, 1988). Furthermore, data without 
internal order of the variables would be best handled via contingency tables 
(Altman, 1991), while data with any type of order should be evaluated by using 
rank order and/or correlation methods (Kendall, 1962). 
 
Dependent or independent data 
Several statistical tests used on oral implants have been based on the hypothesis 
that the variables tested are independent. The statistical method should instead 
be selected after determining weather the variables are independent or not. 
Methods to test for dependence such as Kendall's rank correlation (1948), can 
provide a distribution free test of independence and measure the strength of 
dependence between two variables. Testing a null hypothesis of independence 
between two variables, such as with Spearman's rank correlation (Best & 
Roberts, 1975), could be another alternative. These two correlation methods 
were originally designed for quantitative continuous variables (Lehmann & 
D’Abrera, 1975; Holm, 2007), but the only requirement is in fact that the data 
exhibits ordering to some extent.  
 
The outcome of dental implant studies is usually based on the number of 
implants inserted, failed, withdrawn or judged as successful.  Each patient could 
have had 1 - 7 implants inserted from the start, and consequently everything 
from zero to several implants could have failed during the follow-up period. The 
different numbers of implants at commencement and different numbers of failed 
implants make a dependence calculation complex (Holm, 2007). Furthermore, 
variables in oral implant treatment are often qualitative data displaying a 
categorical distribution, and the measurements have no obvious ordering, i.e. 
they represent a nominal condition. Consequently, evaluations of dependence 
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between oral implants are not easily performed with either of the two 
dependence tests mentioned (Holm, 2007). 
 
To select the correct statistical method for evaluating the outcome of oral 
implant treatment, the purpose of the actual study has to be considered and 
clarified. Three different methods are eligible: survival data analysis; 
comparison of groups; or multivariate analysis.  
 
Survival data analyses  
Follow-up studies on oral implants, evaluated with survival data analyses, could 
analyse the number of successful subjects (patients) but could also give 
information on when failures occur and give a prognosis for the implants tested 
(Cutler & Ederer, 1958.). The assumption of survival analysis (Cox & Oakes, 
1984), both for Kaplan & Meier (1958) and log rank tests (Bewick, 2004), is 
that patients withdrawn or excluded will have the same prospect of success as 
those who continue in the study. Patients who are followed for a short or a long 
period of time will also be expected to have the same survival probabilities, 
independent of when events happen, i.e. no time dependence. However, when 
the number of patients has declined, late failures will adversely affect the result 
more than early failures (Herrmann, 2003). 
 
Life-table models  
Life-table analyses, a development of the classic survival curve, are used to give 
a prognostic figure for the survival of a certain treatment protocol (Cutler & 
Ederer, 1958). The treatment could for example be the replacement of lost teeth 
with dental implants. The analysis then accounts for patients (implants) who 
have died (failed) or have been withdrawn (censored). A life-table presents the 
proportion of surviving, the cumulative success rates, and the proportion of 
“patients at risk”. Subsequently, all events are supervised over time. A life-table 
can also be used to compare two groups of treatments by adding standard errors 
and calculated confidence intervals (Altman, 1991). The total success rates are 
not compared, but rather the success rates at preset time intervals. However, this 
outcome can be somewhat confusing if treatments give a better success rate at 
one preset time period but not at another.  
 
Log rank test 
A better alternative to the life-table technique is a log rank test (Azen et al., 
1977), when survival analyses are performed to compare two (or more) test 
groups. The log rank test is based on the null hypothesis that there is no 
difference between the groups compared. Furthermore, one of the survival 
curves is compared with the expected survival curve of the whole time span. The 
difference in survival curves will be described by P-values to ascertain any 
significance between the compared groups. The log rank test is often used to 
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detect a difference between test groups when the risk of an event is consistently 
greater in one group than the other, and the relative risk does not cross over at 
any time period. Therefore, when analyzing survival data using the log rank test, 
the survival curves should always be plotted first (Gellerstedt, 2006). As the log 
rank test is purely a test of significance, it does not provide an estimate of the 
difference between the groups or a confidence interval. An alternative method 
would be to use a hazard ratio analysis, such as the Cox proportional hazard 
model (Altman, 1991). 
 
Contingency Tables 
When the purpose of a study is to compare groups without considering the time 
aspect, contingency tables (Altman, 1991) could be the method of choice. In 
connection with survival data, contingency tables are also used to compare test 
groups at a fixed time-period. The tables are then referred to as frequency tables. 
Each factor (dimension) is divided into a number of levels, and the frequencies 
of their combinations are registered. Two different correlation tests are 
available: 
Pearson’s chi-squared test 
The Pearson’s chi-squared test (Altman, 1991) is basically the sum of squares of 
the differences between the observed and expected frequencies. Then, each 
squared difference is divided by the corresponding expected frequency. The test 
is normally used when more than two research groups are to be compared.  
Fisher's exact test 
The Fisher’s exact test (Altman, 1991) can be used when only two data groups 
are compared using two by two contingency tables. Furthermore, the test 
calculates the actual probability of the observed two by two contingency tables, 
with respect to all other possible two by two contingency tables within the test. 
The sum of the probabilities for more extreme cases will then be the P-value.  
 
If the purpose of a study, on the other hand, is to detect specific factors 
responsible for the failures, the problem is more complex due to the nature of 
the data. The methods used are multivariate or logistic regression analyses 
which however are still not designed for this kind of complex condition and 
have therefore some limitations (Holm, 2007).  
 
Multivariate analyses 
Multivariate analysis techniques (Marda et al., 1979) are now commonly used to 
evaluate the outcome of oral implant treatment (Wennström et al., 2004; 
Noguerol et al., 2006). These techniques are normally used when several 
variables are present, which are presumed to give a cumulative effect on the 
outcome. The variables may interact independently or may be dependent on 
each other. However, multivariate analyses are mainly complements to 
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univariate tests (Herrmann, 2003) for which multiple interferences and the risk 
of cumulative errors might add up to a total enlarged risk of P>0.05.  
 
In order to identify which group of background factors may have the strongest 
effect on the outcome of a study, a step-by-step multivariate analysis could also 
be used (Herrmann, 2003). In connection with this, a post hoc analysis might be 
used to further determine which specific variable is responsible for the 
significant outcome at each level studied (Hochberg & Tamhane, 1987). 
 
Statistical terms and tests used in oral implant studies 
As seen from the above review some improvements in statistical handling seem 
to be needed, when evaluating oral implant treatment results (Herrmann, 2003).  
 
Descriptive statistics 
Descriptive data for oral implants could be most elusive (Altman, 1991). In 
many medical and dental publications the description of the population studied, 
with regard to hypotheses used and distribution of the population, is often 
lacking. However, number of females and males and age ranges are information 
frequently presented in studies of oral implant outcomes (Buser et al., 1990; 
DeBruyn & Collaert, 1994; Chuang, 2002). 
 
Dependent or independent data 
Several authors have acknowledged dependence, while many others have 
ignored it completely (Bahat, 1993; Buchs et al., 1995; Engquist, 2002; Romeo 
et al., 2006). The existence of a presumed dependence among implants within 
the same jaw is obvious once a prosthetic construction has been attached, a fact 
first recognised by Adell et al. (1990:b). Statistical analysis of the outcome can, 
of course, be started at “the prosthetic level” as suggested by many researchers 
(e.g. Adell et al., 1990:b; Jemt et al., 1993; Leimola-Virtanen et al., 1995). 
However, starting at this level with follow-up evaluations should be avoided 
since all early implant failures would be excluded from the analyses. The first 
researcher to randomly select one implant per patient for calculating the 
statistical outcome on “implant level”, and correctly taking care of a possible 
dependence, was Mau (1993). His method has since been followed by others 
(Cune & de Putter, 1996; Haas et al., 1996). A different way of handling 
dependence using regression analysis has been recommended by Hutton et al. 
(1995) and others (Eckert & Wollan, 1998; Eckert et al., 2001; Chuang et al., 
2002). Recently other methods, such as the Bootstrap or Jackknife techniques, 
have been seen in studies on basic medicine (Brunelli & Rocco, 2006; Liu et al., 
2004; Chen et al., 2006). Only one study on dental implants using the Jackknife 
technique (Yerit et al., 2006), but none with Bootstrap, has been found in the 
PubMed database (2007-01-10). However, the statistical method as such is not 
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discussed as the only information available is that a Jackknife variance estimate 
was used to handle the correlation of implant survivals within the same patient. 
 
Comparisons 
Statistical methods for comparing test-groups are available (Altman, 1991). 
However, sometimes each CSR may be calculated separately before being 
compared (Chiapasco et al., 2001; Pinholt, 2003) in order to identify risk factors 
or to evaluate individual implant systems.  
 
In meta-analyses (Hunter et al., 1982), for which data is combined from 
different studies, dependence amongst the original sample populations may not 
have been fully evaluated (Esposito et al., 2001:a; Hinode et al., 2006). Some 
outcomes included in the meta-analysis may, for example, have been calculated 
with methods handling the dependence while others have not (Esposito et al., 
2001:a; Henry et al., 1996). Furthermore, even if dependence has been 
acknowledged, the statistical methods used may not always account for such 
dependence.   
 
Life-table analyses 
Life-table analyses, such as described by Kaplan & Meier (1958) or Cutler & 
Ederer (1958), are often used when evaluating medical devices such as oral 
implants (Lekholm et al., 1994; Lazzara et al., 1996; Jemt et al., 1996; Lekholm 
et al., 1999; Shin et al., 2006; Romeo et al., 2006). However, it is important to 
acknowledge that life-table analyses are designed to evaluate prognoses for fatal 
diseases, as the name implies (Cutler & Ederer, 1958). Therefore, presenting a 
CSR without exploring the data in the form of a  life-table (e.g. Buchs et al., 
1995; Levine et al., 2002) has clear disadvantages. Many five or ten year reports 
have also been based on only a few patients followed the full time-period 
(Lazzara et al., 1996; Wheeler et al., 1996; Testori et al., 2001; Ferrigno 2002). 
Detailed information on the patients withdrawn or dropped-out is most often 
also missing when the outcome of retrospective studies are presented (Misch et 
al., 2006; Babbush & Shimura, 1993). 
 
Log rank test 
In a retrospective study of patients treated with endosseous implants, 
comparisons between subgroups of patients were made using the log-rank 
statistical test (Mundt et al., 2006). In another study, immediately loaded 
implants and submerged implants were compared (Schnitman et al., 1997), also 
using this test. The log rank test has the advantage  of giving a P-value which is 
often desired by the researcher, especially in medical and dental research. 
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Withdrawal analysis 
In long-term follow-up studies, some patients will be withdrawn or dropped-out 
before the final examination. Albrektsson (1993) described these as 
“unaccounted for” patients and also showed that they exhibit approximately 
twice as many failures as patients who remain within the study. Furthermore, he 
found that withdrawn or dropped-out patients were not interested in being re-
evaluated or were not healthy enough to be re-examined. The reasons for patient 
withdrawals may be documented (van Steenberghe et al., 1990; Jemt et al., 
1991; Johns et al., 1992; Lekholm et al., 1999) or not. However, the patients 
withdrawn influence the treatment outcome even when the number 
“unaccounted for” is relatively low (Albrektsson, 1993). 
 
Lekholm et al. (1994) described a technique based on the assumption that all 
implants not eligible for check-up were failures, i.e. worst-case analysis, instead 
of assuming that they had the same fate as those being followed. The purpose of 
their protocol was to show that there is a discrepancy between patients/implants 
evaluated and the statistically calculated CSR. Later, Mau et al., (2002) 
developed the worst-case protocol further by introducing one more level called 
the best-case analysis, i.e. the opposite, assuming that all implants not being 
followed were successful. Thereafter, they compared the worst or best-case 
assumptions, demonstrating the uncertainty that may occur when too few 
patients were followed. 
 
Considerations on commonly used implant statistics  
From the above review it is clear that the statistical methods currently being 
used in studies of oral implant treatment are not always the most appropriate to 
ensure valid results. Important statistical considerations include:   
 
· A dependence between implants placed within the same jaw has not yet 
been statistically proven to exist before the implants are connected via a 
fixed construction,  
 
· Neither is it known how the outcome of studies  which ignore dependence 
relate to the results of studies addressing dependence and handling the 
data accordingly, 
 
· Survival analyses are normally based on the assumption that withdrawn or 
censored patients (implants) would have the same fate as those being 
followed. However, it is still not fully known how the fate of withdrawn 
or dropped-out patients/implants relates to the outcome of those followed, 
 
· The reasons (selective or random) for withdrawals or exclusion of 
patients/ implants, and also the status of these patients/implants, are most 
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often not discussed in oral implant reports. It has not been shown either 
whether the result would be interpreted differently, if more information on 
withdrawn or dropped-out patients/ implants were known, 
 
· Neither has it been shown whether the risk of implant failure is related to 
patient status, the type of implant or the treating doctor – or a combination 
of these factors, 
 
· Neither is it known whether correct statistical analyses can before 
treatment identify patients with an increased risk of implant failures, 
 
· Several generally different methods for handling dependence are available 
but there is little information on which would be preferable to display 
implant results. The particular situation of unequal numbers of implants 
per patient requires special statistical methods to handle the variance 
calculations,  
 
· Finally, it does not seem to be known whether ignoring dependence would 
affect variances, confidence intervals and P-values, calculated for 
statistical analyses. 
 
The importance of all these factors has not been clarified, and consequently 
more research on these topics is needed and will be the theme of this thesis. 
 
 
PDF created with pdfFactory Pro trial version www.pdffactory.com
 24 
Aims of thesis 
 
The overall objective of this thesis was to study how different statistical tests 
and procedures affect the evaluation of oral implant treatment results. The 
specific objectives of the four investigations included within the thesis were to 
assess, in relation to oral implant treatment:  
 
v whether any dependence exists among individual implants, before 
connecting the implants to a bridgework (study I),  
 
v whether the outcome of life-table analyses is affected by the random 
selection of one implant per patient (study I),  
 
v whether the success rates differ for followed patients or those withdrawn 
or dropped-out from the studies (study II), 
 
v whether there is a threshold for the number of randomly withdrawn or 
dropped-out patients (implants) still allowing valid analysis (study II),  
 
v whether random versus selective withdrawal of patients (implants) exerts 
any influence on the statistical outcome (study II), 
 
v whether any individual patient, clinic or implant characteristics influence 
the implant failure rate (study III), 
 
v whether any combinations of the above individual characteristics 
influence the outcome and could thereby identify high risk patients (study 
III), 
 
v whether a Jackknife method, in conjunction with confidence intervals and 
life-table analyses, reveals the same bone-combination (i.e. high risk 
patient factors) as in study III (study IV), 
 
v whether any combinations of the above individual characteristics display 
a statistical difference (i.e. high risk patient factors) when using the 
Jackknife method in conjunction with a log rank test (study IV). 
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Materials and methods 
 
Original multicentre population  
Four 5-year prospective multicentre (MC) studies (Lekholm et al., 1994; Jemt et 
al., 1996; Henry et al., 1996; Friberg et al., 1997) of oral implant treatment 
(Brånemark implant system by Nobel Biocare AG) concerning the success of 
turned threaded titanium implants constituted the base for the current research 
project. The original purposes of the four investigations were to analyse 
separately the specific treatment protocol by evaluating all implants at regular 
intervals, until the prostheses had served in clinical function for 5 years. All 
studies followed a similar program of research and follow-up protocols. Totally 
edentulous patients were restored with either fixed full dentures or overdentures, 
while partially edentulous patients were treated with either partial replacements 
or single tooth crowns, depending on the number of teeth missing. The four 
studies also followed the guidelines for clinical research extant at the time, 
including the Declaration of Helsinki. 
 
All patients signing up at selected clinics during a pre-specified time-period 
under rigorous inclusion and exclusion criteria were consecutively included in 
the studies.  The patients also had to be willing to comply with the treatment 
protocol in question and the intensive follow-up program, altogether taking 
about 6 years.  According to dental status and treating centre the patients were 
enrolled for the corresponding treatment protocol. Several questions about the 
overall health of the patients focused on conditions known or suspected to 
influence the treatment were noted. However, details of smoking or alcohol 
usage were not registered. At the start of the studies, all included patients were 
reported to be mentally and physically healthy and when appropriate to have 
controlled medications. 
 
The patient inclusion period was approximately 6 months for each study. The 
first surgical session, implant placement, was performed according to routine 
procedures (Adell et al., 1985; Lekholm, 1993). Second stage surgery, abutment 
connection, took place after a healing period of at least 3 months for lower jaws 
and 6 months for upper jaws. The prostheses were thereafter attached within a 
month, again following standardized protocols (Adell et al., 1985). However, 
postponements did occur at patients’ request, delaying the treatment phase, so 
baseline was set when the prostheses were in position. 
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Table 1 
Distribution of patients by MC-study and treatment outcome. 
 
Patients 
MC- study 
Included 
Withdrawn/ 
dropped-out Successful 
Supra-
structures 
at start 
Fixed partial 
bridges 159 26 133* 197 
Overdentures 133 41 92 127 
Single tooth 
Replacements 92 17 75 106 
Fixed full 
bridges 103 20 83* 101 
Total 487 104 383* 531 
* A total of 13 bridges were not removed, but the supporting implants were still 
considered successful 
 
Fifty -five percent of the patients included were females and the mean age of the 
entire group was 51 years (range 15-84 years). Two hundred and fifty-one 
patients had one or several missing teeth needing replacement, while the 
remaining 236 patients were completely edentulous from the start. Of the 
patients treated, 57% received implants in their lower jaw. The total number of 
patients, suprastructures and outcome per study can be seen in Table 1. 
 
During the 5-year follow-up period after attachment of the prosthetic 
suprastructures, the patients were recalled at preset time-intervals. The patients 
included in three of the studies were examined after 1 week, 1 and 6 months, 
and thereafter yearly.  Patients in the fixed full bridge study had their first 
evaluation after 1 year of function. Clinical examinations were combined with 
radiographic evaluations at baseline and after 1, 3 and 5 years. Radiographs 
were used (Gröndahl et al., 1996) as an objective and repeatable confirmation of 
the implant status during the entire study period. To further ensure objectivity, 
independent dental radiologists (at the University of Gothenburg) assessed 
marginal bone heights of each implant and also evaluated whether any signs of 
pathological changes were present.  
 
Whether the implant treatment could be regarded as successful or not was, in 
principle, based on Albrektsson et al. (1986). However, minor modifications 
according to Lekholm et al. (1994) and Herrmann (2003) were also introduced, 
without altering the demand of implant stability, preset maximum of marginal 
bone-loss and absence of complications or pathogeneses. 
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To fulfil the criteria at the final 5-year examination most suprastructures, except 
single tooth restorations, were removed to be able to individually test the 
stability of  each implant. A total of 13 suprastructures in the fixed full and fixed 
partial bridge studies were not removed  but the supporting implants were 
considered successful due to the absence of clinical or radiological signs of 
integration loss. Another 3 patients suffering from parestesia were also regarded 
as successful implant outcomes. Besides the implant success variables, plaque 
index, gingival index, probing depth, bleeding on probing and stomatognatic 
function were also assessed. Prosthetic component failures were also noted 
during the follow-up period. Thus, all complications from first stage surgery and 
throughout the entire treatment period were included in the statistical 
evaluations.    
 
Details of the treatment and follow-up protocols of each MC-study were 
described in the individual 1, 3 and 5-year reports: fixed partial bridges (van 
Steenberghe et al., 1990; Henry et al., 1993; van Steenberghe et al., 1993; 
Gunne et al., 1994; Lekholm et al., 1994; Higuchi et al., 1995), overdentures 
(Johns et al., 1992; Hutton et al., 1995; Jemt et al., 1996), single tooth 
replacements (Jemt et al., 1991; Laney et al., 1994; Henry et al., 1996) and fixed 
full bridges (Olsson et al., 1995; Friberg et al., 1997). 
 
Pooled multicentre study population  
The patients from the four multicentre studies, 487 patients with 531 
suprastructures and 1738 implants, were pooled to create a combined database 
for statistical analyses (Tables 1 and 2).  Among these patients, 323 implants 
were withdrawn or dropped-out from the study before the final check-up, and an 
additional 110 implants were regarded as failures, giving in total 1305 
successfully functioning implants (Table 2).  
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Table 2 
Distribution of implants by MC-study and treatment outcome. 
 
 
Furthermore, of the 487 patients enrolled, 104 failed to complete the entire 
follow-up program. The main reasons for this are presented in Table 3. 
Primarily, 73 of the 104 patients did not complete the studies due to 
death/hospitalization or non-compliance during the follow-up period, including 
persons refusing radiographic and/or clinical examinations at the final follow-
up. Thirty-one additional patients did not complete the study, whereof 25 were 
considered to have a negative change of therapy. Twenty patients experienced 
complete failures of their initial implant rehabilitation and consequently had to 
be retreated with conventional prostheses, while another five had involuntarily 
changed prosthetic solutions. Finally, six more patients had to be excluded, since 
they had requested a new prosthetic rehabilitation not corresponding to the 
originally planned treatment. The majority of these were overdenture 
restorations in which a fixed full bridge had to replace the original implant 
supported denture. 
 
 
 
 
 
 
 
 
 
 
 
 
Implants 
 
MC- studies 
 
Patients 
 
Inserted 
 
Failed Withdrawn/ dropped-out 
 
Successful 
Fixed partial 
bridges 159 558 36 84 438 
Overdentures 133 510 44 127 339 
Single tooth 
replacements 92 107 3 18 86 
Fixed full 
bridges 103 563 27 94 442 
Pooled 
population 487 1738 110 323 1305 
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Table 3 
Distribution of reasons for withdrawal of patients within the four MC-
studies. 
 
Reasons for withdrawal of patients 
MC-studies Death or 
hospital-
ization 
Total 
failure 
Non 
Comp-
liance 
Changed 
therapy 
(complication) 
Changed 
therapy 
(requested) 
Fixed partial 
bridges 9 7 8 2 0 
Over- 
dentures 6 9 20 1 5 
Single tooth 
replacements 2 1 11 2 1 
Fixed full 
bridges 11 3 6 0 0 
Pooled 
population 28 20 45 5 6 
 
Thirteen percent or 62 of the 487 patients treated experienced implant failures, 
while the remaining 425 patients had no failures (Figure 5). The mean number 
of implants inserted per patient was 3.57 (1738/487 ) and the corresponding 
failure rate was 0.23 with a standard error of 0.755, representing everything 
from single to multiple implant failures in the patients followed.  
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Figure 5 
Distribution of implant failures across patient population. 
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The number of failures against the number of implants placed per patient can be 
seen in Figure 6.  
 
Figure 6 
Distribution of implant failures against number of implants inserted. 
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Methods and statistical analyses used 
 
Study I – Evaluation of dependence 
Dependence between implants within the same jaw was calculated over the 
pooled population using the procedure described below. Single implants and 
patients withdrawn or dropped-out prior to abutment connection were excluded 
from this analysis, giving a total of 1639 implants for the dependence 
assessment. To evaluate any dependence among implants within the same jaw, 
before the implants were connected to a prosthetic construction, the following 
estimates were created:  
- the independent variance (V0 ) was estimated from a binomial distribution 
assuming no dependence between the implants. 
- the dependent variance (V)  was estimated from a general discrete distribution.  
 
The following statistical formulae were then used to determine whether any 
dependence existed: 
V0 = mq (1-q),  
V = m2 (åy2i) - (åmi2) (åyi)2/ m2- (åmi2), 
where: 
m = total number of implants,  
q = frequency of failures 
mi = number of implants placed per patient 
yi = number of failed implants per patient (before loading) 
y2i = squared number of failed implants per patient, respectively. 
 
If V > V0 - it was concluded that a dependence was substantiated. 
 
In order to handle the dependent data, one implant per patient was selected. 
Manual randomisations to select one implant from each of the 487 patients were 
repeated five times using a randomisation chart (Pocock, 1983).  Five unique 
“one implant per patient” groups were constructed, by beginning at different 
starting points on the chart. Individual life-tables (Kaplan & Meier, 1958) were 
then calculated for each of the five unique groups and a range of Cumulative 
Success Rates (CSR:s) for these were established.  Finally, CSR:s were also 
calculated for the “all inserted implants/per patient” population, for comparison 
with the five individual CSR:s described above.   
 
Study II – Analyses of withdrawn or dropped-out patients 
A new “one implant per patient” population was constructed out of the pooled 
population for study II, by the previously described random selection technique 
(Pocock, 1983).  However, information provided after the original multicentre 
studies and study I had been concluded was then included in the pooled 
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population. These updates did not change the number of implants in any of the 
groups – placed (n=487); withdrawn or dropped-out 16% (n=80); successfully 
functioning 76% (n=371); and/or failed implants 7% (n=36). 
  
In order to study the effects of incomplete data, the following three different 
approaches were used to investigate how well the outcome of the patients 
withdrawn or dropped-out corresponded with the results of patients followed: 
 
Originally withdrawn or dropped-out patients 
To study if the withdrawn or “unaccounted for” patients had the same success 
rates as those evaluated - a hypothesis used in a standardized life-table analysis - 
attempts were made to again recall the “unaccounted for” patients. All former 
responsible investigators from the MC- studies were contacted and asked to re-
examine previously withdrawn or dropped-out patients for the outcome of the 
implant treatment. If the patients did not return for a new check-up, the 
investigators were asked to find from their charts, if the patients had been 
examined regarding the implant outcome at any time after the MC-studies 
closed, and information from that examination was added to the pooled 
database. Repeated letters and e-mails requesting the information were sent to 
optimise the answering frequency. 
 
Random withdrawals  
To study whether there was a definite borderline percentage of the “one implant 
per patient” population that could be disregarded without affecting the outcome, 
25% of the patients were successively and randomly withdrawn or dropped-out. 
Thus, three separate subgroups, called A, B and C, were created from the pooled 
population.  Each random selection was performed starting from a new patient 
number in the current population to avoid selecting the same patients for all 3 
groups. The same randomisation chart as mentioned before was utilized until 
only 75% (A); 50% (B); 25% (C) of the patients remained, respectively (Table 
4).  
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Table 4 
Distribution of random selections of the patients in study II. 
 
Implants 
Populations Patients 
At start Failed Withdrawn /dropped-out Successful 
Total 487 487 36 80 371 
Group A 362 362 25 58 279 
Group B 244 244 18 42 184 
Group C 119 119 5 25 89 
 
Life-table analyses (Kaplan & Meier, 1958) and chi-squared tests (Altman, 
1991) were then used to study the implant outcomes of the randomly withdrawn 
or dropped-out patient groups A, B and C.  
 
Withdrawals based on patient characteristics 
In order to evaluate whether selected withdrawals based on patient 
characteristics interfered with the outcome, new subgroups were created out of 
the “one implant per patient” population. This time the patients were first 
selected by age, i.e. less than 51 years of age or over 59 years of age. Patients 
between 51 and 59 were disregarded during this selection to separate the 
younger and older patient groups. Secondly, the patients were selected by 
gender and jaw type. Thereafter, subgroups - for females or males and treatment 
in upper or in lower jaws - were created out of the pooled population (Table 5). 
Both Chi-square calculations and life-table analyses were then performed with 
the selected populations. However, CSR:s were not calculated for the age 
groups, since the middle age-group was disregarded.  
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Table 5 
 Distribution of selections of patient characteristics. 
 
Patient Implants 
  At start Failed Successful 
Female 216 15 201 Gender Male 271 21 250 
a <50 211 12 199 
b 51-59 99 Excluded Age 
c >59 168 16 152 
Upper 208 24 184 Jaw Lower 279 12 267 
 
Study III – Evaluation of potential prognostic risk factors 
The pooled population (487 patients) of study II was also used as a basis for the 
analyses in study III. However, some minor changes of the database were then 
made to facilitate the separate statistical analyses, as described below for 
evaluating potential prognostic factors for oral implant failures:  
 
Individual patient characteristics  (level one in the multilevel analyses) 
1. Gender: Male or female. 
2. Age-group: Three groups were analysed: a) patients younger than 51 
years; b) middle aged patients being between 51 and 59 years; and c) 
patients 60 years of age or older. 
3. Treated jaw: Maxilla or mandible.  
4. Bone-quality: Four classifications were used, where bone-quality 1 
mainly represented cortical bone, and qualities 2, 3 and 4 represented 
gradually decreasing quantities of cortical bone being replaced by 
increasing amounts of bone marrow (Lekholm & Zarb, 1985). To 
evaluate whether any significant differences in failure frequencies 
could be detected between the 4 bone-qualities, Fishers exact test was 
used (Altman, 1991). The first variable to be tested was bone-quality 1 
against qualities 2, 3 and 4. Thereafter, qualities 1 and 2 were 
compared with 3 and 4. Finally, qualities 1, 2 and 3 were tested against 
bone-quality 4. A boundary between the compared groups was 
declared, when the very first statistical difference between the 
compared groups was established. Two subgroups with a significantly 
different outcome were thereby established, which were later used for 
bone combination analyses. 
5. Jaw-shape: The population was divided into five groups (A, B, C, D, 
E), where jaw-shape A represented the least resorbed jaws and jaw-
shape E the most extremely resorbed ones (Lekholm & Zarb, 1985). 
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The same procedure as described under point 4 above was also used to 
identify a boundary between the 5 jaw-shape groups. It should be 
noted that all single tooth patients were excluded, giving a total of 395 
patients remaining for this analysis. 
6. Treatment protocol: Four types of prosthetic treatment were 
compared; fixed partial bridges; overdentures; single tooth 
replacements and fixed full prostheses.  
 
When testing the variables, by using conditional binomial tests 
(Herrmann, 2003), multiple analyses were applied to evaluate each 
individual case with the mean of the others. A 499-sized bootstrap 
simulation was used in order to  achieve a correct multiple significance-
level (Efron & Tibshirani, 1993).  
 
Clinic/treating doctor characteristics   (level one in the multilevel analyses) 
7. Supporting implants/prosthesis: The original numbers of implants 
placed and construction-supporting were used when evaluating this 
variable. When a patient had two or more prostheses, only the 
restoration being supported by the randomly selected implant(s) was 
analysed. Twenty-one patients had to be excluded because of implant 
failure or non- compliance. Thereby, 466 remaining patients 
participated in the “implants/prosthesis” calculation. A Pearson chi-
square test (Altman, 1991) was used to evaluate whether the number of 
implants, from single implants up to 7 implants supporting the 
prosthesis, had any significant effect on the outcome.  
8. Responsible clinic: Each clinic was regarded as one unit, without 
differentiating between treating surgeon and prosthodontist. However, 
more than one team of surgeons and prosthodontists could have been 
involved in the study but still would all be evaluated as one unit. 
 
Individual implant characteristic  (level one in the Multilevel analyses) 
9. Implant length: Five groups of implant lengths, i.e. 7; 10; 13; 15; and 
18 mm or longer, were analysed.  Fourteen implants, wider in diameter 
than the commonly used Ø 3.75 mm implants, were excluded from the 
individual implant length evaluations.  
 
Combinations of individual jaw-bone characteristics  (level two in the multilevel 
analyses) 
10. Combinations of bone-qualities and jaw-shapes: Four different jaw-
shape/quality combinations (Table 6) were constructed for the 395 
patients for whom these two variables were originally identified (point 
4 and 5 - individual patient variables). Combination I represented 
implants placed in shapes/qualities A, B, C / 1, 2, 3. The shapes A, B, 
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C and qualities 1, 2, 3 have previously shown the lowest failure rates 
when evaluated on the first level of the multilevel analyses. 
Combination II consisted of implants placed in jaw-shapes and bone-
qualities D, E / 1, 2, 3. Combination III consisted of implants placed in 
jaw-shapes A, B, C combined with bone quality 4. Finally, 
combination IV consisted of implants placed in bone types (D, E/ 4), 
which showed the highest failure rates on level one (points 4 and 5). 
 
Table 6 
Distribution of bone-qualities and jaw-shapes with regard to the four 
subgroups forming the different bone-combinations. 
 
Jaw-shape* 
 Bone-quality* A B C D E 
1 
2 
3 
 
Combination I 
 
Combination II 
 
4 Combination III Combination IV 
*according to  Lekholm & Zarb (1985) 
 
Implant lengths within constructed bone-combinations (level three in the 
multilevel analyses) 
11. Influences of implant length within the jaw-shape/-quality 
combinations (I; II; III; IV): Each of the four combinations mentioned 
above (point 10 - combinations of individual jaw-bone characteristics) 
was divided into two new subgroups by the length of the implants 
inserted (7 and 10 mm versus 13 mm or longer), all of 3.75 mm 
diameter. 
 
Analyses 
Multilevel analyses were performed as a step-by-step method using chi-squared 
tests (Altman, 1991) on three levels. Furthermore, post hoc analyses (Hochberg 
& Tamhane, 1987) were used to identify whether an individual value differed 
within any of the samples tested; treatment protocol, jaw-bone quality, jaw- 
shape, implant length, number of implants per prosthesis, bone-combinations, 
and implant length within the jaw-bone combinations. The post hoc analyses 
were based on a multiple significance level of less than 0.05 for the detailed 
analyses. 
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Study IV - Evaluation of variances using the Jackknife method 
The same, pooled population was employed as in studies II and III, but this time 
all implants inserted were analyzed. As mentioned before, the single tooth 
patients from one of the original MC-studies were only categorised with regard 
to bone-quality (density). To enable these patients to be included in the analysis 
of bone related combinations (I–IV), the following approximations were made 
and added to the pooled database. When a 7 mm implant was placed, the jaw 
shape (quantity) was assumed to be group E (extremely resorbed bone), 10 mm 
implants were assessed to group D, 13 mm to group C, 15 mm to group B, and 
18 mm or longer to group A (most bone available), respectively. 
 
Combinations of jaw-shapes and bone-qualities were then constructed in the 
same way as described in study III (point 10 – combinations of bone-qualities 
and jaw-shapes). However, this time patients from the single tooth study were 
also included, giving a total of 487 patients.  
 
To prepare the population for the Jackknife method (Quenouille, 1956), the total 
population was divided into equally sized subgroups. One single tooth patient 
representing a successful outcome was excluded (n=487-1) to obtain an equal 
number of patients (n=54) in the subgroups (9). Thereafter, an adjusted 
randomization chart (Pocock, 1983) was used to give an almost equal 
distribution of patients from the various MC-studies in the 9 subgroups, 
allowing a maximum discrepancy of two patients per MC-study. Each patient 
was randomly allocated to one of the 9 subgroups, regardless of the number of 
implants inserted in the patient. Furthermore, one by one a different subgroup 
(n=54) was excluded giving 9 unique Jackknife samples based on the remaining 
8 subgroups (n=432).  
 
Standard errors were estimated (Altman, 1991) for the four bone-qualities (I-IV) 
using the nine Jackknife subgroups in relation to the preset time-periods. The 
standard errors were then used to emphasize uncertainties of the CSR:s for the 
six time-periods.  
 
Calculation of CSR:s was performed for all 486 patients (1737 implants) and 
also for the four combinations (I-IV) separately, using the pooled population 
without Jackknife rearrangement of the data. For this purpose the standard life-
table principles were utilized (Kaplan & Meier, 1958). Moreover, as previously 
stated, (study III - point 10) combination IV differed significantly from the three 
other combinations, the latter three groups were amalgamated and analysed as 
one sample (combinations I-III). Finally, confidence intervals (CI:s) were 
calculated  and used to test whether the difference between the CSR:s  
(combinations I-III versus combination IV) was significant. 
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A log rank test (Cox & Oakes, 1984; Altman, 1991) was used as an alternative 
statistical test for differences in survival distribution between the two groups of 
combinations (I-III vs IV). An ordinary log rank test was computed using all 
data. In the log rank test a ratio of excess failure number and standard error was 
computed for the preset time-periods. The test was then repeated after the 
Jackknife re-sampling method to again estimate the difference between the 
results, but this time taking dependence into account.  
  
Overall statistical principles 
In order to study the statistical queries presented in the aims and material & 
methods, the following conditions were applied: 
· Implants not followed throughout the entire study-period were included in 
the evaluations for as long as they were surveyed. Detailed information on 
withdrawn or dropped-out patients was published in the separate 5-year 
reports and has been presented in Table 3.  
· The patients included in the pooled populations were assumed to be 
independent of each other. 
· Chi-square tests used were either Pearson’s or Fishers exact tests 
depending on the number of groups to be compared (Altman, 1991). 
· When performing the significance analyses, withdrawn implants were 
included. 
· Multiple interferences, including separate evaluations, were not formally 
taken into consideration for post hoc analyses.  
· SPSS (Statistical computer program from SPSS Inc, Chicago, Il., USA) 
and Mathematica (Wolfram Research Inc, Champaign, Il. USA) were 
used for the statistical evaluations.  
· The statistical program R (Swedish University Computer Network, 
Uppsala) was utilized, and also the New S Language: A Programming 
Environment for Data Analysis and Graphics, (Becker R, Chambers JM, 
Wilks AR, Chapman Hall NY (1988). 
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Results  
 
Study I – Evaluation of dependence   
The distribution of implant failures seen in Figures 5 and 6 and the distribution 
of individual implant failures indicated a dependence existed prior to any 
statistical calculations were performed. 
 
The variances calculated were 60.1 for the discrete distribution (V) and 41.9 for 
the binomial distribution (V0). Thus, V was found to be bigger than V0, 
indicating that a dependence among the implants within the same jaw clearly 
existed prior to loading.  
 
The CSR:s of the 5 manually randomised “one implant per patient” samples 
were 91.4%, 91.8%, 92.2%, 93.1% and 92.2%, after 5 years of clinical function. 
The results indicated that the “one implant per patient” technique could be a 
valid method when evaluating data affected by dependence.  
 
Finally, the 5-year CSR for all inserted implants was 92.7%, which is within the 
range of the 5 manually randomised “one implant per patient” values (91.4-
93.1%), despite the fact that established dependence was ignored.  
 
Study II – Analyses of withdrawn or dropped-out patients 
Originally withdrawn or dropped-out patients 
In all clinical trials, some of the patients included will fail to complete the entire 
study protocol. In the current MC-studies, 21% or 104 patients were not 
evaluated or had failed completely after 5 years, whereof 15% or 73 patients 
failed due to lack of cooperation.  
 
The answering frequency to update requests for the withdrawn or dropped-out 
patients was very low and only 3 of the centres did respond. One main reason 
for this was that 69% of the doctors previously responsible for the study subjects 
were no longer working at those clinics. The response from the treating centres 
stated that 9 of the 56 withdrawn or dropped-out patients had attended for a 
check-up after the MC- studies had been concluded.  The fate of the implants in 
47 “unaccounted for” patients remained unknown. Consequently, no conclusions 
regarding the true fate of the implants in the originally withdrawn or dropped-
out patients could be drawn.  
 
Random withdrawals 
The CSR:s of the randomly withdrawn or dropped-out patient groups (Table 7; 
Figure 7) after 5 years of follow-up were calculated as the following: group A 
(25%) 92.9%, group B (50%) 92.5% and group C (75% withdrawn or dropped-
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out) 95.7%. When all patients (100%) were evaluated the comparative 5-year 
CSR was 92.4%. When the number of withdrawn or dropped-out patients 
reached 50% (as in group B) the CSR:s remained the same (92.5%) during the 
last three years of follow-up. Corresponding figures for group C were 95.7% for 
the last four years. Unchanged CSR:s were obtained for the last three to four 
time-periods in groups B and C. However, the corresponding figures constantly 
decreased when the entire population was analysed (96.3, 94.2, 93.5, 93.3, 93.1, 
92.4%). This showed that the risk for missing identification of late implant 
failures increased when the test samples became too small. Consequently, it was 
concluded that only 25% of the patients could be “unaccounted for” to maintain 
the same pattern of survival as in a certain full population. However, when chi-
squared tests were performed on the same subgroups (A, B and C), no 
statistically significant differences (P>0.05) could be demonstrated.  
 
Table 7 
Distribution of CSR:s (%) for the total population and with 75% (A), 50% 
(B) and 25% (C) of the patients remaining in the groups, respectively. 
 
Time-period 
Total 
population 
Group 
A 
Group 
B 
Group 
C 
Placement-loading 96.3 96.7 96.3 98.3 
Loading–1 years 94.2 94.4 93.8 96.6 
1-2 years 93.5 93.6 93.0 96.3 
2-3 years 93.3 93.3 92.5 96.3 
3-4 years 93.1 93.3 92.5 96.3 
4-5 years 92.4 92.9 92.5 96.3 
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Figure 7 
Distribution of CSR:s (%) for the total population and with 75% (A), 50% 
(B) and 25% (C) of the patients remaining in the groups, respectively. 
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Withdrawals based on patient characteristics 
The selective withdrawals, based on treated jaw, resulted in a strong statistically 
significant difference (P<0.01) in implant outcome, when chi-squared tests were 
used. Thereafter, the CSR:s were computed to 88.3% and 95.5% for upper 
versus lower jaws. By contrast, no significant differences (P>0.05) were 
observed for gender; the corresponding CSR-values were 92.0% for females and 
92.8% for males.  
 
Study III – Evaluation of potential prognostic risk factors 
Over-all results 
Significant or strongly significant differences were observed with potential 
prognostic factors for implant failures: jaw; jawbone quality; jaw-shape; 
treatment protocol; implant length and jawbone related combinations. However, 
no significant differences in implant failures were observed for; gender, age 
groups and responsible clinic or number of implants supporting the restoration 
(Table 8).  
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Table 8 
Parameters contributing to risk of implant failure, studied by chi-square 
tests and post hoc analyses (multiple P level .05). 
 
Parameters evaluated X2 
Simulated 
limit of 
individual 
P-value 
Outstanding 
sample 
P-value 
for outstanding 
sample 
Level One 
Patient 
characteristics:  
Gender: 
Male or female P>0.05 Not tested   
Age group: 
<51, 51-59 or >59 
years 
P>0.05 Not tested   
Jaw: 
Maxilla or Mandible P<0.01 Not tested   
Bone-quality: 
1, 2, 3 or 4 P<0.001 0.0226 
Bone-quality 
4 
0.00013 
 
Jaw-shape: 
A, B, C, D or E P<0.001 0.017 
Jaw-shapes 
D, E 0.00009 
Treatment protocol: 
Fixed partial bridges, 
overdentures; single 
tooth replacements or 
fixed full prostheses 
P<0.05 0.0146 overdenture 0.0029 
Treating doctor/clinic 
characteristics:  
Supporting 
implants/prosthesis P>0.05 0.015 none 0.29 
Responsible clinic P>0.05 Not tested - - 
Individual implant 
Characteristics:  
Implant length P<0.001 0.018 7 mm implant 0.0004 
Level Two 
Combinations of 
individual jaw-bone 
characteristics: 
 
Combination I, II, III 
or IV P<0.001 0.0083 
Combination 
IV 0.0006 
Level Three 
Implant lengths (long 
or short) within the 
jaw-bone combinations 
I, II, III or IV 
P>0.05 >.0125 none 0.05 
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Individual patient characteristics 
Neither gender nor age influenced the outcome (P >0.05). However, when 
testing the outcome by jaw treated (upper versus lower), and the four different 
treatment protocols, significant differences (P <0.05) could be seen. With the 
post hoc analyses, overdenture (OD) rehabilitation was the one treatment that 
differed significantly from all other protocols  
(P =0.0029). The OD study had 17 failures of the 133 implants placed (12.8%), 
while failures were 3.3% in the single tooth study, and 6.9% in the fixed partial 
and 4.9% in the fixed full prosthesis studies.  
Strongly significant differences (P <0.001) were found for both bone-quality 
and jaw-shape analyses. Post hoc analysis showed that the highest failure rate 
and lowest P value (24.5% and P = 0.00013) occurred for jawbone quality 4. A 
similar high frequency of failure and low P value (21.0% and P = 0.00009) was 
demonstrated for jaw-shapes D and E together.  
 
Regarding clinic/treating doctor characteristics 
The “supporting implants/prosthesis” evaluation indicated the highest failure 
rate (13.0%) for prostheses supported by four implants. However, the failure 
frequency decreased when the restorations were supported via 3 or less implants 
or by 5 or more implants. No significant difference (P > 0.05) could be detected 
for the “supporting implants/prosthesis” analysis per se. Neither could the post 
hoc analyses detect any group that significantly differed (lowest  
P = 0.29) from any of the other groups (1-7 implants/restoration).  
 
Furthermore, when evaluating the influence of the treating clinic, the descriptive 
statistics confirmed that some of the clinics had experienced no failures at all, 
while others had 10-30% implant failures. Despite this, no significant 
differences (P >0.05) were observed for the responsible clinics.  
 
Individual implant characteristics 
Implant length was one factor that demonstrated a strongly significant difference 
(P <0.001). The post hoc analysis showed that the 7 mm long implants had the 
highest failure rate (21% and P = 0.0004). Combining 7 mm and 10 mm 
implants still produced a high failure rate (13.1%) and the p-value was even 
stronger (P = 0.00003). This combined group was also significantly different 
from the outcome of the 13-20 mm long implants. When the 7 and 10 mm 
implants were compared with each other, a significant difference (P-value 
<0.05) was also noted. 
 
Furthermore, when evaluating whether the implant length corresponded with the 
given jaw-shape structure, it was demonstrated that in jaw-shape E was 83% of 
the placed implants 7 mm long. The corresponding figure for jaw-shape D was 
57% for implants with a length of 10 mm.  
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Regarding combinations of individual jaw-bone characteristics  
Strongly significant differences (P <0.001) were also established for the 4 bone-
combinations. Looking into details - combination I (implants placed in jaw-
shapes and bone-qualities A, B, C / 1, 2, 3) had the highest success rate of 95% 
(15 failures out of 296 inserted implants) Seventy-five percent of the patients 
belonged to this group. For combination II (representing 13% of the patients), 6 
of 51 implants inserted failed (12%) in jaw-shapes known to have low success 
rates and in bone-qualities having high success rates (D, E / 1, 2, 3). 
Combination III, (with 9% of the patients) consisted of implants placed in areas 
where adequate jaw-bone was available (jaw-shapes A, B or C) but the jaw-bone 
quality (4) was poor. In this group 5 of 37 implants failed (14%).  Finally, 3% of 
the patients belonged to combination IV, which had the highest failure rate (7 of 
11 implants failed – 64%), consisting of implants inserted in jaw-shape and 
quality (D, E / 4). The post hoc analyses confirmed that the worst prognosis  
(P = 0.0006) would be with the latter combination.  
 
Regarding implant lengths within constructed bone-combinations 
Adding implant length (7 and 10 mm versus 13 mm or longer) to the bone 
combination analyses, as the last (third) level in the multilevel analyses, no 
significant difference could be detected.  
 
Therefore, the multilevel analyses identified bone-combination IV as the 
condition most strongly correlated with a high failure rate while implant lengths 
could be disregarded. Hence, this bone combination can be considered the most 
valuable variable for predicting failure risk in this patient group.  
 
Study IV - Evaluation of variances using the Jackknife method  
The total number of inserted implants in the nine Jackknife subgroups (each of 
54 patients) varied between 184 and 204. The mean failure rate was 6.3% and 
individual failure rates for the nine Jackknife subgroups varied from 2.0 to 
9.6%. Furthermore, the majority of the implants (1311) were inserted in 
combination I (130-173 implants/subgroup). Only 40 implants were placed in 
combination IV, with a range from 0 to 14 implants per subgroup.  
Standard errors (SE:s) varied by more than a power of 10 between the Jackknife 
samples (each of 432 patients) across the preset time-periods and jawbone 
combinations. Over all follow-up periods, the lowest standard errors were found 
in combination I (0.0037/time-period 1; and 0.0088/time-period 6), and the 
highest in Combination IV (0.0510 for time-period 1 and 0.079 for time-period 
6).  
 
Life-table analysis calculated a CSR of 93.4% after 5 years of clinical function 
for the 1737 implants placed in the 486 patients of the pooled population. The 
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CSR for combination IV was 54.8%, while the CSR:s for the other three bone 
combinations were 95.3% (I); 92.1%  
(II) and 90.2% (III).  
 
The 95% confidence interval on CSR:s for combinations I-III ranged from 
97.9%  +/- 1.5  to 94.4% +/-1.6 after 5 years. The corresponding figures for 
combination IV were 77.5% +/- 12.2 and 54.8% +/-15.9. Furthermore, the CSR 
for combination IV was about 20% lower than for the other combinations, once 
the prostheses were attached to the abutments and decreased a further 22% 
during the 5-year follow-up period. No overlapping of CI:s was noted at any 
time, indicating a statistical difference (Figure 8). 
 
Figure 8 
Diagram showing the distribution of CSR:s and corresponding CI:s for 
combinations I-III versus IV in relation to time-periods studied.  
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
1 2 3 4 5 6
Time  pe r iods
Upper  CIs f or  Comb I- III
CSR f or  Comb I- III
Lower  CIs f or  Comb I- III
Upper  CIs f or  Comb IV
CSRs for Comb IV
Lower  CIs f or  Comb IV
 
 
Log rank test 
The standardized log rank test showed an excess failure number of 15.86 at the 
preset time-periods. Together with a standard error of 1.43, a ratio of 11.09 was 
computed. Subsequently, a strongly significant difference was established (P< 
0.001) between combinations I-III and combination IV. A different result was 
seen with the standard error calculated from the nine Jackknife samples. The 
standard error for the nine Jackknife samples was 6.02 while the excess failure 
number remained the same i.e. 15.86. Thereby, the ratio decreased to 2.63, 
giving a less significant difference (P-value = 0.015). Consequently, when 
dependence was ignored it gave too strong a significance level.   
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Discussion  
 
Population considerations 
The purpose of this thesis was to study possible influences of some statistical 
aspects on the outcome of long term evaluations of oral implant treatment, 
identifying factors to be considered before new findings are given any rightful 
acceptance in the clinical practice. 
 
In the mid-eighties the research division of Nobel Biocare AB (Göteborg, 
Sweden) introduced clinical trials in the field of oral implants, making it 
possible to undertake this study, as the trials produced a unique database of 
documentation. Four of the prospective MC-studies initiated at the time used the 
design of simplified pharmaceutical trials,  but only one included a control 
group (Friberg et al., 1997). Furthermore, qualified statisticians were responsible 
not only for the statistical evaluation but also for the supervision and analysis of 
the data collected. Steering committee meetings were also held throughout the 
studies, in order to verify that all conclusions were correctly interpreted, with 
focus on evaluated variables, before publishing the results.  
 
However, after pooling the 4 MC-studies mentioned, the information of which 
has been used in this thesis, it was possible to identify both similarities and 
differences between the 4 parts building the database, differences that have to be 
considered when assessing the outcome: 
 
· The patients included in the 4 different studies had, for natural reasons, 
different numbers of implants supporting the constructions, ranging from 
one single implant to seven implants. This created a challenge of course, 
since the number of failure/s also varied, which must be taken into 
account when conducting statistical evaluations.  
 
· The different prosthetic constructions also divided the material, since the 
outcome of the overdenture protocol significantly differed from the other 
treatments. However, it should be noted that the majority of the failures 
that were observed occurred early, prior to the prosthetic treatment or 
during the first year of function, and mainly in maxillas having 
compromised bone status. 
 
· The full bridge study did not include any early follow up visits, i.e. after 1 
week, 1 month and 6 months, in order to spare the patients unnecessary x-
rays and excessive clinical evaluations. However, if a complication 
occurred during this period that information was still included in the 
registrations.  
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· Variables such as stomatognathic and periodontal evaluations, including 
oral hygiene and bleeding indices, pocket depth measurements and 
bleeding on probing registrations, were not recorded in the full bridge 
study since the other MC-reports included had not statistically associated 
those variables with documented failures. 
 
· From the start, the experience of individual surgeons and prosthodontists 
was not regarded as a potential risk factor, as the selected clinics were 
acknowledged to be experienced in the implant treatment protocols being 
tested. 
 
With all differences identified within the population studied, it is also 
important to emphasize the similarities that were observed. 
 
· The 4 MC- studies in general used the same inclusion and exclusion 
criteria for patient selection.  
 
· The sample sizes of the test-groups were decided with the aim of having 
at least 100 patients in each group at the end of the follow-up period. 
 
· The very same success criteria were used in all the 4 MC-reports. 
 
· The study design regarding treatment and yearly follow up sequences was 
the same in all the 4 MC-protocols.  
 
· The individual patient health registrations did include information on 
diabetes, hypertension, allergies, colitis, and autoimmune diseases and 
medications, but not detailed information on smoking or drinking habits, 
previous infections of implant sites and/or on possible traumas. 
 
· No recommendations on how many teeth each implant could or should 
support were given in any of the studies either. 
 
Thus, the pooled patient population used in the current thesis was in many ways 
well defined but from other aspects some variations did exist. However, none of 
the differences mentioned were regarded as of any hindrance to a satisfactory 
performance of the current statistical evaluations. Consequently, the database 
was considered well suited for the elaborations that were to be carried out.  
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Study I – Evaluation of dependence   
The results of study 1 showed from a mathematical point of view that a clear 
dependence existed among implants placed in the same jaw. The dependence 
identified was demonstrated to exist even before the prosthetic constructions had 
been attached. This outcome was obtained after looking upon the population in 
two different ways. First, it was calculated how many of the inserted implants 
had failed, assuming that implant failures had a binomial distribution. Secondly, 
the distribution of implant failures was studied, assuming the population was 
generally discretely distributed. However, in the current population, patients 
with only one implant failure were less common than those having no or more 
than one implant loss. This fact strongly indicates that if one implant has failed, 
the risk for more failures will increase for the same patient, i.e. dependence 
among the implants placed in the same jaw thus exists.  
 
In order to handle the established dependence in the current study population, 
the “one implant per patient” technique (Mau, 1993) was utilized. This 
procedure was repeated 5 times and corresponding life-tables were constructed 
to calculate the 5-year CSR:s. By doing the randomisation manually, it was 
possible to see which specific implant was randomly selected, each time. The 
CSR:s ranged from 91.4 to 93.1 %, which indicated that the “one implant per 
patient” technique could give repeatable outcomes. When evaluating all the 
implants inserted, disregarding the established dependence, the CSR was 92.7%, 
i.e. within the range of the previously established CSR:s. However, the 
established dependence should still not be ignored in future evaluation studies. 
 
No mathematical formulae to test for an anticipated dependence have been 
published (PubMed 2007-02-10), even although other authors have discussed 
potential causes of dependence among implants placed in the same jaw (Adell et 
al., 1990:b; Hutton et al., 1995; Cune & de Putter, 1996). 
 
Adell et al. (1990:b) e.g. were the first authors to raise the subject of dependence 
in the oral implant literature and they presented a protocol that has been 
favoured by many others (Jemt et al., 1993; Lekholm et al., 1994; Leimola-
Virtanten et al., 1995). However, Adell et al. (1990a) used the prostheses as the 
evaluation level instead of the implants, a correct method from a statistical point 
of view, but seen from the researcher’s side, has some drawbacks. One is that all 
implant failures occurring before the prostheses have been attached would be 
disregarded, and most implant failures do occur prior to the connection of the 
prosthetic construction (Friberg et al., 1991; Snauwaert et al., 2000). Another 
drawback is that before the patient would be scored as a failure, all implants 
supporting the prosthesis have to fail. This indicates that the “Adell method” 
(Adell et al., 1990:a) is a rather insensitive technique, as complete treatment 
failures do rarely occur (Degidi et al., 2006). 
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Mau (1993) also stressed the challenge of dependence among implants placed in 
the same jaw. He, on the other hand, suggested performing the evaluation on the 
implant level and introduced the “one implant per patient” technique. The 
procedure to randomly select one of the patient’s implants for the statistical 
evaluations has since been used by many others (Cune & de Putter, 1994, 1996; 
Haas et al., 1996, Chuang et al., 2001). Haas et al. (1996) investigated the 
repeatability of the technique. However, they used a computer program to repeat 
the procedure 500 times, instead of using manual selections. They found that by 
randomly selecting one of the inserted implants it was possible to achieve 
trustworthy CSR:s, each time. In the study by Chuang et al. (2001), three 
alternatives for handling dental implant data associated with dependence were 
used. The first alternative was the “one implant per patient” protocol; the second 
was testing the population for the hypothesis of independence, and the third one 
utilized all implants when testing the hypothesis that dependence existed. 
However, the authors did not find any differences between the outcomes of the 
three methods, and therefore these studies confirm the outcome of the current 
paper I. 
 
Some researchers have disregarded the existence of any dependence, when 
selecting statistical evaluation methods (Engquist et al., 2002; Payne et al., 
2002). One reason for this could be the lack of clarity over how to best handle 
dependence. Another reason might be that the final outcomes do not always 
show great differences, regardless of whether dependence is ignored or not 
(Chuang et al., 2002). A third reason could be the uncertainty that is created 
when evaluating only one of the implants inserted; thereby losing information 
about all other implants. Therefore, the question on how to handle dependence 
has led several research centres to use more and more sophisticated methods to 
solve the problem. Hutton et al. (1993) used a logistic regression model with 
backward selection for testing confounding influences and interactions. Eckert 
& Wollan (1998) on the other hand used the Cox proportional hazard model, 
while Chuang et al. (2002) used a clustered failure-time multivariate model, a 
method that they subsequently recommended for evaluating oral implants. 
However, none of the authors mentioned have demonstrated mathematically the 
existence of the dependence or have statistically shown that their method would 
give significantly different results, if dependence were to be acknowledged.  
  
Consequently, study I is the first report in which dependence between implants 
has been mathematically demonstrated and acknowledged. The “one implant per 
patient” technique was also proven to be a simple and repeatable method for 
handling this dependence.  
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Study II – Analyses of withdrawn or dropped-out patients 
The result of study II showed that random exclusion of patients did not affect the 
outcome much as long as 50% of the treated patients were followed the entire 
study period. If the excluded patients, on the other hand, were selected and not 
randomly chosen, the results could be significantly affected, depending on 
which of the selective variables was used for the sampling. 
 
The outcome was obtained by randomly excluding groups of 25% of the 
population 3 times, leaving either 75% of the followed patients for group A, 
50% for group B or 25% for group C. To exclude 25% each time may be 
regarded as an imprecise way of studying the effect of sample sizes. However, 
the purpose was not to find an exact borderline, but to study possible influences 
on the final outcome of  portions of missing data. 
 
From the life-table analyses used, the 5-year CSR:s for groups A and B showed 
results that corresponded well with the CSR of the entire population. However, 
when looking at the failure-times, implant losses were missed in all groups 
already after the second follow-up year, more frequently in groups B and C than 
in group A. This indicates that when the failures are few, which is often the case 
after the 2nd year of follow-up in oral implant studies (Adell et al., 1990:b; Zarb 
& Schmitt, 1990; Esposito et al., 1997), the risk for randomly excluding the few 
failures occurring is considerable, something that of course cannot be ignored.  
 
No corresponding differences were detected, however, when using the paired 
chi-square test (Altman, 1991) for the same groups of patients (A, B and C). 
One reason for this could be the sample size in relation to the numbers of 
failures occurring. Another could be that the point of time for implant failure 
does not influence the result of the chi-square test. A third reason could be that 
the subgroups were created from one and the same database, and therefore some 
of the randomised patients could have belonged to more than one of the groups 
A, B and C. However, just because no differences between the subgroups were 
detected does not prove that the outcomes were equal. 
 
When selectively excluding patients on the bases of gender, age or treated jaw, 
and still using the life-table approach and the “one implant per patient” 
technique (Mau, 1993), completely different outcomes were reached. For 
example, selection by jaw treated clearly showed a dramatic decrease in CSR, if 
the patients excluded were treatments in lower jaws. However, if females/males 
or different age groups were selected, no differences between these aspects 
could be detected. Also when the three variables were evaluated individually by 
chi-square tests (Altman, 1991), the only statistically significant difference 
demonstrated was between maxillas and mandibles. This emphasises the 
importance of always separating the results with regard to jaw type treated. On 
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the other hand, age and gender, which are often addressed in oral implant studies 
(Babbush et al., 1986; Buchs et al., 1995; Snauwaert et al., 2000), do not seem to 
be so important to the final implant outcome. 
 
Before starting the elaborations with the current database, several attempts were 
made to recall the withdrawn or dropped-out patients of the 4 MC-studies, in 
order to evaluate the status of this missing population. However, very few 
patients did return for re-examination. One reason for this could be that the 4 
studies were conducted more then 10 years earlier, and consequently several of 
the originally responsible investigators of the MC-studies were no longer 
working at the clinics involved in the reports. Another reason could be that the 
withdrawn patients were true drop-outs and could not or did not want to be re-
examined. The fact that withdrawn or dropped-out patients remain “unaccounted 
for” has previously been confirmed by Roos et al. (1997). 
 
No statistical evaluations of random or selective exclusion of patients in 
connection to follow-up of oral implant treatment have been found in the 
literature (PubMed 2007-02-15). However, some studies have selected or 
excluded patients on the basis of, for example, excluding maxillary treatments 
(Arvidson et al., 1992; Leimola-Virtanen et al., 1995), whilst other studies with 
broader recruitment have confirmed more frequent failure in the treatment of 
maxillae, especially when bone quality and quantity are poor ((Buser et al., 
1997; Sennerby & Roos, 1998; Henry, 1999; van Steenberghe et al., 2002; Jemt 
& Hager, 2006).  
 
Consequently, it is obvious that patient/research populations must be properly 
presented regarding current characteristics, and at least 50 %, but preferably 
75%, of patients included should be followed the entire study period, in order to 
obtain trustworthy CSR:s and reliable times for implant losses. Furthermore, if a 
study population does not represent all types of patients, but only selections of 
these with features that may significantly affect the statistical outcome (such as 
good prognostic factors); this should be recognised in follow-up reports. 
 
Study III – Evaluation of potential prognostic risk factors 
Potential risk factors for implant losses were analyzed in study III, using a 
multilevel approach and post hoc analyses to identify patients at risk of implant 
failure.  
 
The elaboration started by testing the research variables individually to search 
for significantly better or worse prerequisites for implant failures. The most 
important individual patient characteristics found to be related to a significantly 
higher failure rate were: maxillae, bone quality type IV, jaw shapes D and E and 
overdenture treatment. These factors have previously been associated with 
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decreasing implant success rates also by others (Babbuch et al., 1986; Hutton et 
al., 1995; Truhlar et al., 1994; Lazzara et al., 1996; Sennerby & Roos, 1998; 
Snauweat et al., 2000; Kourtis et al., 2004). 
 
Variables showing no correlation to implant failures were: age-group and gender 
(as also discussed in study II)  clinic/ treating team, and the number of implants 
supporting the prosthetic restoration. However, no detailed information was 
available for deeper analysis of the effect of clinic/treating doctor. This was 
because all information on specific surgeon or prosthodontist treating patients 
was unfortunately missing. A difference in success rates has previously been 
shown  between surgeons (Lambert et al. (1997), which has been referred to as 
the learning curve. 
 
In the current study, the risk of implant failures was highest with constructions 
supported by 4 implants. However, neither more nor fewer implants per 
construction showed significantly different outcome. Certainly, the risk of 
overloading the implants ought to increase when the number of implants per 
construction is decreasing. The opposite effect, with a greater risk of introducing 
static forces due to misfit seems likely, when more implants are connected to the 
construction (Rangert et al., 1989). 
 
The only individual implant-related factor tested, (implant length) demonstrated 
significantly better results for longer implants than shorter ones. The 7-mm long 
implants showed the worst prognosis, (a failure rate of more than 20%) closely 
followed by the 10-mm long implants, with a 10% failure rate. There was also a 
significant difference between the results of these 2 implant lengths. 
Furthermore, a strongly significant difference was demonstrated between 
implants longer than 10-mm compared to the 7- and 10-mm long ones. Short 
implants have previously been associated with high failure rates (Snauwaert et 
al., 2000; Weng et al., 2003; Jemt & Hager, 2006). However, the new finding 
from this study was that the 10mm long implants caused a significantly higher 
failure rate than the 13-mm or longer implants. It should be noted, however, that 
long implants can not and should not be placed if insufficient bone  is present. 
This was also illustrated by the fact that in jaw-shape E mainly 7-mm long 
implants were placed, indicating that even implant length is a kind of patient 
related characteristic. 
 
When looking for prognostic risk factors, combinations of the worst conditions 
were tested in study III. At the first evaluation level in the multilevel analyses, 
the border lines between the best and the worst conditions for bone quality and 
jaw shape were statistically established. Thereafter, and based on the outcome, 
the second level tested statistical differences between the four newly created 
bone combinations (I-IV). At the third evaluation level, implant lengths were 
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added to the 4 bone combinations as the only individual implant characteristic to 
be tested. However, no statistical differences were seen between the shorter and 
the longer implants, even though 7 of the 9 short implants failed in bone 
combination IV. Probably no significant differences were found because too few 
implants in this combination were available for analysis. 
 
Consequently, the most important risk factor demonstrated was the presence of 
both poor bone quality and inadequate jaw-bone volume as in combination IV. 
Fortunately, this combination was only seen in 3% of the total patient 
population. When the bone-related combinations were good, on the other hand, 
the failure rate dropped dramatically as in combination I, where only one of 20 
patients experienced an implant failure. Seventy-five percent of all patients 
belonged to that combination. The high failure rate seen in patients with poor 
jaw-bone quality and extremely resorbed jaw-bone volumes has also been 
reported by others (Friberg et al., 1991; Jaffin & Berman, 1991; Lekholm et al., 
1999; Kourtis et al., 2004; Friberg et al., 2005). However, the combination of 
these two bone-related factors identifying high risks of implant losses has not 
been reported previously. 
 
Study IV - Evaluation of variances using the Jackknife method 
The result of study IV clearly demonstrated a statistical difference between the 
amalgamated sample based on jaw-quality/-shape combinations I-III and 
combination IV. When performing the calculations, the Jackknife re-sampling 
method was used together with life-table analyses and the log rank test. The 
outcome coincided well with the outcome of study III, in which the “one implant 
per patient technique” and the life-table analyses were utilized. Consequently, it 
was possible via three different statistical evaluation procedures to show an 
increased failure risk for patients with jawbone quality 4 and jaw-shape D or E, 
i.e. the combination IV according to Herrmann et al. (2005). 
 
In order to include the patients from the single tooth study in the current report, 
the missing information regarding jaw shape was adduced from the length of 
implant placed. Of course, this approximation was a rough way of judging the 
jaw-volume, as a 7-mm implant could have been placed in any type of jaw 
shapes. However, looking at implants placed in jaw shape E, in the 3 other MC-
reports (van Steenberghe et al., 1990; Johns et al., 1992; Olsson et al., 1995), the 
majority were found to be 7mm long.  
 
The Jackknife re-sampling technique restructured the implant sample sizes for 
the 9 Jackknife subgroups, each consisting of 432 patients. The failure rates 
varied from 2% to almost 10% for the subgroups, which was interpreted as 
showing that dependence did exist between implants placed in the same jaw. 
Furthermore, the standard errors for the 4 bone combinations studied and the 6 
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time-periods evaluated varied over the Jackknife samples. The greatest variances 
were seen for the combination IV group, which however only consisted of 40 
patients, when being compared to combination I (n=1311). Combination IV also 
had the highest standard error (0.08), i.e. a power of ten times higher than 
combination I (0.008). Of course, the unequal sample sizes of the two 
combinations contributed to this difference. In order to simplify the test-model, 
the combinations I, II and III were amalgamated into one group when testing for 
the patients with the highest risks of implant failure. The Jackknife technique 
used could have been replaced by other techniques such as the Bootstrap 
procedure,  when performing the current calculations. However, this would not 
have added any more information about the evaluation of variances. Besides, 
only one study of oral implant outcomes with the Jackknife, and none using the 
Bootstrap procedure, have been found in the literature by PubMed 2007-02-15, 
yet these two  methods are often used in medical studies to calculate variances 
(Svensson, 1993). Therefore, using the Jackknife technique in the present report 
was an innovation in assessing oral implant treatment results. 
 
Calculated CSR:s together with corresponding confidence intervals clearly 
demonstrated discrepancies between the two populations of combinations  I-III 
and IV, as seen in Figure 8. It is important to note that the CSR:s obtained 
included all implants without first re-arranging these, while the CI:s were 
calculated using the Jackknife technique only. However, success rates of oral 
implants are most frequently calculated by life-table analyses, so if a comparison 
between groups should be conducted, CI:s ought to be added to the CSR:s. 
Alternatively, the log rank test could have been utilized, but both these methods 
still require some re-arrangement of the data. To illustrate the importance of 
correct consideration of the dependence, the standard errors used in the ordinary 
log rank test were compared to those calculated with the Jackknife re-sampling 
method. The log rank test values were approximately 25 per cent of the current 
Jackknife values, indicating that if the SE:s were underestimated, an inaccurate 
strong significance level might be reached. That is of course unacceptable. 
Alternative methods for handling dependence based on regression models or 
multivariate analyses have also been suggested (Eckert et al., 2003; Chuang et 
al., 2002; Eckert et al., 2001). 
 
Consequently, the two statistical methods used in the current paper showed 
similar outcomes for oral implant treatment results as the “one implant per 
patient technique”. It is important to consider, though, that the established 
dependence has to be addressed in some way when dealing with follow-up data. 
The Jackknife re-sampling procedure combined with the log rank test or the life-
table analysis seem possible ways of handling this problem.   
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Study design and statistical considerations 
The declaration of Helsinki was written to protect human beings from 
unnecessary clinical tests and experiments (World Medical Association, WMA). 
According to the declaration, clinical trials should only be conducted when the 
study outcomes are expected to give new and valuable (for the patient) 
information about the variables being tested. One way to meet this demand is to 
perform sample size calculations prior to conducting the trials, to ensure 
statistically valid results can be achieved (Altman, 1991). The goal for each of 
the MC-studies, included in the present thesis, was also to have at least 100 
patients to be evaluated at the 5-year final examination level and to be equally 
distributed among the participating clinics. It has previously been suggested 
(Albrektsson & Zarb, 1993) that 50 patients from at least 2 centers should have 
been followed to be able to claim valid long-term follow-up results. The 
database of the current thesis  fulfilled this requirement well, as the pooled 
material used consisted of around 400 patients from several different clinics 
evaluated after 5 years. Mau et al. (2002) suggested that the sample size should 
be increased by 10-15% to ensure an acceptable test population at the end of the 
follow-up period. However, 15% of the current patients were lost to follow-up 
during the five-year research period, despite several attempts made to re-
examine the lost patients both during the MC-study period and when conducting 
study II. An over sized research population of 115-120% therefore ought to be 
planned at commencement, at least for five year follow-up studies. 
 
When the current MC-studies started in the mid 80-ies, the purpose was not to 
compare different oral implant systems but to evaluate the success rates of four 
different treatment protocols, using one and the same implant technique – the 
original Brånemark implant procedure. At the time, it was not fully understood 
and documented, though, which variables influenced the outcome achieved; 
which was first evaluated later in study III. However, the MC-reports were the 
very first prospective MC-studies conducted according to defined and 
reproducible principles. For example, the MC-studies used the same study 
design, inclusion and exclusion criteria and success and failure criteria, 
(Lekholm et al., 1994; Jemt et al., 1996; Henry et al., 1996; Friberg et al., 1997). 
The effect of different study designs has been discussed by several authors 
(Eckert et al., 2003, 2005; Esposito et al., 2001:b, 2005; Iacono & Cochran, 
2007), of whom Eckert et al. (2003) noted the importance of having a clear 
purpose and correct study design from the start in order to achieve a significant 
follow-up outcome.  
 
Clinical trials are often conducted to acknowledge or reject a hypothesis, e.g. if a 
new treatment procedure or device is tested, the hypothesis is that the new one is 
significantly better than a control procedure. An established protocol or product 
could then be used as the control. However, only one of the current MC-studies 
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included a control group, since Nobel Biocare AB was conducting the 4 MC-
reports on the Brånemark system. The exception was the full fixed bridge-study 
(Friberg et al., 1997), in which a new self-tapping implant design (from Nobel 
Biocare AB) was compared with the original non-self-tapping Brånemark 
implant. Comparisons with any concurrent systems were thus not performed at 
the time. It would also have been possible to use traditional well-documented 
crown or bridge treatments of teeth (Karlsson, 1981) for the control purpose. 
However, the research committees responsible abandoned this possibility due to 
the completely different evaluation methods and success criteria being used for 
teeth and implant studies. 
 
Due to the nature of the implant data, the results of the separate MC-studies 
were calculated with survival analysis (Altman, 1991). This is a technique which 
works very well for oral implants as long as the inclusion period is limited. If 
inclusion continues throughout the entire follow-up period, the number of 
implants at the start might be much higher than the number actually followed up. 
The literature frequently shows retrospective and even prospective reports based 
on less than 10% of the patients treated from the start, i.e. 90% or more of the 
subjects used for the calculations can be “unaccounted for” data (Babbush & 
Shimura, 1993; Ferringo et al., 2002). This means of course that substantial 
information regarding the fate of these patients/implants must be lacking. All 
life table analyses have, though, a rescue calculation built into the model to 
handle the “missing data”, assuming that the “unaccounted for” have the same 
fate as those who have been followed (Kaplan & Meier, 1958). It should be 
noted that life table analysis was originally designed for fatal diseases, as the 
name suggests; not the same as oral implants. To some extent, worst case or 
best/worst case analyses could be used as complements in these situations to 
reveal the strength of the outcome (Mau et al., 2002). However, a better 
alternative seems to be to only refer to the CSR:s when 75% (or at least 50%) of 
the population have been evaluated, as also suggested in paper II.  In some cases 
this would mean that only the outcome of the first follow-up years can be 
regarded as reliable, even if longer follow up periods are available (Herrmann, 
2003).  
 
As early as 1993, Albrektsson et al. (1993) shared the concern of including too 
many “unaccounted for” subjects when using life table analyses and therefore 
suggested the use of the four-field presentation protocol. However, this method 
does not facilitate statistical evaluations such as life-table analysis using CI:s. 
The four-field technique was therefore not used in the current thesis. Exploring 
the full life table, and not only the CSR:s, and using strict individual success 
criteria, also reveals the fate of the individual implants being followed, thereby 
eliminating a presentation of survival based solely on the group outcome.  
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Oral implant studies display a clustering pattern as discussed in paper I, as 
acknowledged and addressed by many authors (Hutton et al., 1995; Eckert & 
Wollan, 1998; Eckert et al., 2001; Chuang et al., 2002). Poor bone quality in 
combination with small bone volume was identified in the current thesis as the 
major reason for implant failure with expected failure rates of 30-60%. 
Therefore, patients with these characteristics would make a much better test 
population for evaluating implant design changes (such as surface texture 
alterations) than the standard population with expected success rates of 90% or 
more. However, no controlled studies are available in the literature in which 
combination IV has been used to evaluate new surfaces or other implant design 
features. One exception is Hallman et al. (2005), who used compromised 
jawbones needing bone grafting in such an approach. In their study they 
compared implants with a turned surface with those having a roughened texture, 
but the study included also a grafting protocol as mentioned.  
 
In order to evaluate the outcome of oral implants, some basic information 
regarding the studied population needs to be addressed. It seems reasonable to 
use a chi2 -test, e.g. the Pearson test, when evaluating the implant failure rates, as 
in papers II and III, since the Chi2 test is used for categorical data and tests each 
group against the other in a four field table. Other authors have previously used 
the chi2-tests for oral implant data (Morris et al., 2004; Fransson et al., 2005). 
However, figures and diagrams can also give information about the population 
and the strength of the outcome without focusing on significant differences 
(figure 5-7). One example of this was in study IV, where a diagram 
demonstrated the difference between two groups and the strength of this 
difference was calculated from the variances for the different time periods 
studied (Figure 8). A much stronger difference was seen in paper IV with the log 
rank test before the data were rearranged with the Jackknife technique. This 
indicates that obtaining P-values whilst ignoring the dependence may wrongly 
conclude a statistical difference, which of course is not acceptable.  
 
In paper III, the purpose was to look for variables causing clustering effects as 
reasons for implant losses. Each research level was then evaluated separately, 
using a multivariate step-by-step technique. Such analyses have previously been 
used in other reports for similar purposes (Ferreria et al., 2006; Noguerol et al., 
2006). Logistic regression analysis has been used when searching for prognostic 
indices in patients assumed to have a cluster pattern in their implant failures 
(Laine et al., 2006). Chuang et al. (2002) also found logistic regression analysis 
served this purpose. However, an important difference from logistic regression 
analysis, is that multivariate analysis handles both dependent background 
variables and dependent result variables, while the logistic regression only takes 
care of the dependent background variables. Evaluations of dental implants are 
extraordinarily complex, since the number of implants inserted can vary from 1 
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to 7 or more, and the number of failures may vary from zero to all of the 
implants. Furthermore, implants inserted within one patient are dependent 
regarding their background factors, and the result variables may also be 
dependent (Holm, 2007). Consequently, when only searching for background 
factors, multivariate analyses such as the step-by-step technique and/or the 
logistic regression analysis, seem to be suitable procedures to use. The dental 
implant data should then first be re-arranged, using a Bootstrap or Jackknife 
technique, which will improve the outcome of the logistic regression model. 
However, when searching for risk factors, multivariate analyses, life tables with 
confidence intervals and/or log rank tests were used in the current report, and 
they seemed to work well as long as the dependence was acknowledged and 
addressed accordingly. 
 
Implant related variables, such as implant surface texture, implant diameters and 
designs, were not analyzed in the present study, since the current data only 
related to the original Brånemark implant system. This is because in the 1980ies, 
the turned (machined) implant of one diameter dominated the placements 
performed and therefore only implant length was available as an implant related 
characteristic in the current report.  
 
Retrospective publications and available long-term controlled prospective 
studies have drawbacks when it comes to comparing new implant features with 
well known ones. One reason for this is that most research activities at present 
only focus on implant design and/or surgical and prosthetic procedures. A 
second reason is that some of the comparative studies extant do not have implant 
success as the main variable evaluated but assess only one of the other success 
criteria, such as marginal bone loss (Balshi et al., 1996; Lindquist et al., 1997). 
A third reason is that the follow-up time in many situations is not long enough, 
while published data have shown implant failures do still occur after several 
years of function (Esposito et al., 1997; Snauwaert et al., 2000). This, of course, 
further complicates the evaluation of new surface textures, when only short 
follow up periods are available (Albrektsson & Wennerberg, 2004; Friberg et 
al., 2005). A fourth reason is that the sample size is not large enough, when 
success rates of both tests and controls are expected above 90%. Besides, the 
product cycle is becoming shorter and shorter (Millenium report, 2005), and 
consequently products may already be replaced before long-term follow-up data 
in scientific reports, companies’ individual warranty systems, or the FDA’s or 
other authorities failure reports, are available.  
 
Recently, Eckert et al. (2005) asked six of the major implant companies for their 
recommended documentation on clinical long-term success of oral implant 
treatment in order to compare different implant systems. Fifty-nine of the sixty-
nine reports sent in did not, however, qualify as valid clinical long-term 
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documentation. Furthermore, Eckert et al., (2005) stated that the remaining 
studies demonstrated no obvious differences in success rates. The pooled 
material of the Eckert study (2005) showed a 96% success rate with a 
confidence interval from 93 to 98%. No individual implant brand demonstrated 
success rates statistically better than the total success rate. Therefore, the studies 
should be designed so a statistical difference can be identified; for instance by 
using patients with compromised bone. Otherwise the Helsinki declaration is 
contravened in that unnecessary studies on humans should not be conducted. 
Equally good success rates would only be acceptable, if some negative side 
effects can simultaneously be reduced. For example, if the cost could be reduced 
to increase the number of patients who can benefit from implant treatment by 
using generic products that would be one such extra positive effect, provided 
that the same quality of treatment is reached. Fewer component complications 
(for example due to a higher grade of titanium), decreased pain and discomfort 
and/or shorter treatment times would be other possible effects that could count. 
Therefore, changes in product lines should give the treating doctors and their 
patients some benefits instead of just a marketing activity, i.e. there should 
always be a patient-value to newly introduced components and/or treatment 
procedures. 
 
In summary, the scope of this thesis was not to cover all statistical aspects of 
validating oral implants. Rather it was to enlighten some challenges in using 
statistical methods without full understanding of the nature of the data studied or 
the statistical formulae used. Furthermore, to compare the outcomes of different 
statistical analyses, some basic statistical rules were violated such as using 
several statistical methods on the same material. However, the purpose was not 
then to search for significances, but rather to evaluate the strength and 
repeatability of the different outcomes. It has also been the hope that the 
outcomes of the thesis will help other researchers and clinicians to conduct their 
follow-up studies in an improved way in the future, using a better study design 
and the best statistical procedures. 
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Summary of Results 
 
The most important finding of this thesis overall was that implants within the 
same jaw demonstrated an interdependence and that this dependence could be 
handled via suitable statistical methods for dependence analysis combined with 
well established statistical methods.  
The separate findings were: 
 
v A clear dependence among implants within the same jaw existed even 
before the attachment of the prosthetic construction (study I),  
 
v The “one implant per patient” randomisation technique did not affect the 
outcome of the life-table analyses of implant treatment results (study I), 
 
v Information about the true withdrawals was too limited to draw any 
conclusions regarding their correlation to the outcome of implants 
followed (study II), 
 
v A cut-off limit for the percentage of randomly withdrawn or dropped-out 
patients could be set at approximately 25%, before any effects on the 
statistical evaluation of the results were observed (study II), 
 
v The selective non-random withdrawal of patients did influence the 
statistical outcome, when evaluating dental implant outcomes, and 
therefore, the reasons for the withdrawals need to be acknowledged (study 
II), 
 
v Patient related characteristics were identified to be the most important risk 
factors, by using a multilevel approach based on chi-squared and post hoc 
tests (study III),  
 
v High-risk patients were found when the jaw bone-combination was D, E/4 
- bone types, which, however, were only observed in a few percents of the 
population (study III),   
 
v The same risk bone-combinations D, E/4 were also identified by the 
Jackknife re-sampling method combined with life-table analyses and 
confidence intervals (study IV), 
 
v A statistical difference was also established for these risk bone-
characteristics when studied by the Jackknife method with the log rank 
test (study IV).  
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Future considerations  
 
Based on the present thesis there are some important issues to be addressed and 
to consider, when in the future designing or evaluating clinical trials on oral 
implant treatments. 
 
The currently observed established dependence among implants within the same 
jaw should  never be ignored when evaluating oral implant outcomes. From this 
thesis it was clear, that two methods can be used to handle this dependence, i.e. 
the “one implant per patient” or the Jackknife technique. The former procedure 
seems easy to handle and understand, while the Jackknife method is more 
efficient since all observations are included in the estimates.  
 
Furthermore, the Jackknife technique, when used in combination with the log 
rank test, showed that the variances were more pronounced than if dependence 
was ignored and an ordinary log rank test was used. Therefore, the use of log 
rank tests, assuming independence, could underestimate the obtained standard 
errors, which may incorrectly lead to too high p-values and too strong 
significance levels. The recommendation is, consequently, to always re-arrange 
the data with the Jackknife method whenever variances are part of the 
evaluation.  
 
In every prospective study it is inevitable that patients will be withdrawn or 
dropped-out. Consequently, the withdrawn and dropped-out levels should be 
addressed in the result presentation and should be allowed for at study start by 
increasing the number of patients to be included by 15-20% to ensure the 
desired sample size after 5 years of follow-up.  
 
As currently also shown the CSR:s, calculated from life table analyses based on 
decreasing numbers of followed patients, may not always give a true picture. 
The long-term outcome, presented as CSR:s, should therefore instead be based 
on the result of at least 50%, and preferably 75%, of the patients included from 
the start. Consequently, the referred follow-up time should also be limited to 
periods, for which at least 50% of the patients are available for evaluation. This 
condition is even more important if the characteristics of the unexamined 
patients are not known, since some patient characteristics to be associated with 
higher failure frequencies.  
 
The most important prognostic risk factors associated with patient 
characteristics found in this thesis were jaw treated, bone quality, jaw shape and 
combinations of the two latter variables. Three percent of the currently studied 
patients represented Combination IV, i.e. jawbone quality 4 and resorption 
degree D or E, and in this group two out of three of these patients experienced 
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one or more implant failures. Thus, this combination constituted the most potent 
risk variable. Consequently, it is necessary to always report the jaw bone 
characteristics when addressing oral implant outcomes as an otherwise good 
implant result might be hidden behind too good jaw bone variables, i.e. guided 
patient selection.  
 
Finally, as jaw-combination IV resulted in the most failures, it would be more 
appropriate to use patients with this bone status when evaluating new products 
and/or treatment procedures, as a significance could be detected and still having 
a realistic sample size. One prerequisite is of course that there is a difference 
between the products. 
 
To introduce new components with similar success rates when evaluated on an 
average population regarding bone status is insufficient unless other positive 
side effects accrue. However, if a new surface treatment designed for poor bone-
quality can improve the outcome for patients with jaw-combination IV it would 
give these patients added value and be accepted on the market. 
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Abbreviations and Explanations  
A 
B 
Binomial distribution: is the simplest distribution to be used for discrete data, 
representing the number of times a certain event occurs.  
Bootstrap simulation: a simulation method to estimate statistical properties.  
C 
CI: Confidence interval 
CSR: Cumulative success rate 
Categorical distribution: means that the observations have qualitative values.  
Censored: the subject is no longer followed, i.e. the endpoint. 
Chi-square test: is a non parametric test for comparing distributions. 
Cohort: is a statistical term for a limited group that has been followed.  
Confidence intervals: are interval estimates including uncertainty of calculated 
values.  
Contingency table: tables with two or more categorical characterisations.  
Cumulative success rates (CSR:s): are calculated by taking the success rate 
(SR) of an actual time-interval multiplied with the cumulative success rate of the 
previous interval. 
D  
Dependence: the opposite to independence. 
Discrete distribution: means that the observations take on separate numerical 
values, e.g. integers. 
E 
Endpoint: is often equal to death or a failed treatment (e.g. implant loss). 
Exclusion criteria: a reason for not including as patient in a study. 
F 
Fisher's exact test: Fisher's exact test is used when 2 groups are compared by a 
2x2 contingency table. 
G 
H 
Hypothesis: is a specific assumption about a population. It concerns the value 
of a specific parameter, which characterises the population.  
I 
IMZ: Cylindrical implant with an HA coat. 
Independence: exists if the joint probability density is the product of the 
individual probability densities, regarding two random variables, e.g. - A and B - 
are independent, when the probability is that any given value of A is not affected 
by value B.  
Inclusion criteria: a reason for including a patient in a study. 
J 
Jackknife re-sampling method: is used to estimate statistical properties for 
data.  
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L 
Life-table: Life-tables for survival analyses are methods to be used on cohort 
mortality populations.  
Log rank test: is a statistical test for survival data.  
M 
MC-study: Multicentre-study. 
Multiple tests: consist of a number of tests, with a given total multiple level of 
significance, which protects against wrongly rejecting any true hypothesis.  
Multifactor analysis: means a test considering several background factors 
(covariates).  
Multiple inference: means the prescribed total risk of error for several tests and 
confidence intervals. 
Multivariate analyses: involve considerations of subjects, which can be 
characterised by several variables. 
N 
Nominal data: are more than two categories but no obvious ordering of the 
categories, e.g. implant surfaces. 
Non-parametric tests: are used when qualitative data are to be measured, or 
limited assumptions about the distribution are at hand.  
Normal distribution: is the most common distribution (also called Gaussian 
distribution), which is defined by mean and standard deviation.  
Null hypothesis: is a basic assumption that there is no statistical difference, e.g. 
that two population means are equal. 
O 
Ordinal data: Non- numerical data defined by verbally described borders 
between the groups. 
P 
Parameter: is a description of the whole population, e.g. mean age, median 
blood pressure etc. A more statistical definition is a theoretical characterisation 
of the population, e.g. the probability (p) for a certain outcome in that 
population. 
Parametric tests: are used when a specific assumption about the distribution 
(e.g. normal distribution) is available. 
“Patients at risk” is a term used to describe - all patients (or e.g. successful 
implants) being alive at the start of the next time interval together with half of 
the withdrawn or dropped-out patients (implants) during that time interval.  
Pearson’s chi-squared test: The test is used to compare observed frequencies 
with those expected, where the null hypothesis of the row and column 
classification factors is independent. 
Post hoc analysis: is used, when an overall hypothesis has been rejected, to 
identify the reasons for the rejection, or to identify which subgroup is 
responsible for the significant outcome.  
Probability (p): is an estimate of how likely an event is to occur. 
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Prospective: means to have an agreement, prior to the start of the study (e.g. a 
study protocol), on how the upcoming events should be analysed.  
P-value: is the probability that obtained outcome or more extreme outcomes 
will occur, calculated under the null hypothesis.  
Q 
Qualitative: means a type of data that can also be called categorical (e.g. 
female/male).  
Quantitative: means a type of data that can be counted or physically measured, 
i.e. numerical.  
R 
Regression analysis: is an analysis to study influence of factors on a variable.  
Randomization: means a random allocation of subjects into different treatment 
groups to avoid bias.  
Random Effect Model: is a statistical test used to handle data that is not 
necessarily independent. 
S 
SLA: Sandblasted and acid-etched surface. 
Selected: is the opposite to random subject allocation.  
Significance level: is the pre-selected probability of rejecting the null 
hypothesis, when it IS in fact true.  
Standard deviation: the mean size of the variation of a random variable.  
Standard error: the mean size of the variation of an estimate of a parameter. 
Statistical method: concerns the mathematical evaluation of models of 
observed data e.g. a statistical test. 
Statistical model: is a mathematical picture of the reality. 
Statistical formulas: are the mathematical calculations to a statistical model.   
Step by step method: is performed by adding one background factor at a time, 
e.g. patient-, jaw- and/or implant- characteristics. 
T 
TPS: Titanium plasma-sprayed surface. 
Treatment protocols: are bridges or overdenture for edentulous patients and 
single tooth replacement or partial bridges. 
U 
“Unaccounted for”: i.e. withdrawn or dropped–out patients. 
V 
Variable: is a description of a subject, e.g. gender, age, health status etc. A 
more statistical definition is an empirical characterisation of a subject.  
Variance: Square of the standard deviation. 
W 
Withdrawn/Dropped-out: means subjects who have not completed the entire 
follow-up program. 
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